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The Microbiology Department of the Prince of Wales Hospital (PWH) 
detected HRV in 2180 (21.3%) of 10,251 stool samples from patients with 
diarrhoea, between July 1985 and April 1994. HRV were found predominantly 
(82.8%) in patients during their first eighteen months of life. Diarrhoea due to 
HRV was seasonal, 69.2% of cases occurring in the winter months, November 
through February 
Of 1825 specimens, were analysed by polyaciylamide gel 
electrophoresis (PAGE), 84.3%, showed the typical electrophoretic pattern of 
group A rotavirus' genomic dsRNA segments. A long electropherotype was 
found for 75.9% of specimens (165 strains, 84.2%), a short electropherotype or 
RNA pattern (31 strains, 15.8%) in 7.1% and 1.3% were indicative of mixed 
infection. For 15.7% of specimens no genomic RNA was visible. 
Reverse transcription-polymerase chain reaction (RT-PCR) was used to 
identify rotavirus genotypes and was able to successfully overcome the 
drawbacks of the established monoclonal based enzyme immunoassay. Of the 
651 specimens, 75.7%, could be amplified to produce the full-length cDNA 
copy of the VP7 gene which subsequently served as template for the 
genotyping. Using this method 76.6% of all specimens could be typed of which 
82.3% had a long electropherotype and 40.8% with a short pattern. More of the 
specimens could be typed this way than by mEIA (66o/o)38. Genotype 1 
specificity was found in 443 (68.0%) specimens, with 25 (3.8%) genotype 2, 17 
(2.6%) genotype 3，and 14 (2.2%) were genotype 4. Each electropherotype was 
found to have a single genotype-specificity, though many different strains 
possessed the same genotype. Of those electropherotype positive specimens, 
containing a single HRV strain and still available, 1365 (95.9%) could be typed 
using a combination of electropherotyping and RT-PCR genotyping. This 
allowed the identification of 870 cases (68.5%) as having genotype 1 
specificity, 100 (7.9%) genotype 2，277 (21.8%) genotype 3, and 24 (1.8%) 
genotype 4. Ten atypical specimens were identified during the study. A total of 
122 specimens were typed by both mEIA and RT-PCR. There was a 98% 
agreement with specimens that had been positively typed by both methods. 
There is a high degree of genetic variability within the HRV population 
in Hong Kong. RT-PCR genotyping is a sensitive method capable of typing 
most of the HRV specimens, particularly when taken in association with 
electropherotyping. This study has demonstrated that RT-PCR genotyping is a 
useful alternative to mEIA for typing rotavirus. 
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• Introduction 
1.1 Introduction to the genus rotavirus 
The genus rotavirus is a member of the Reoviridae family, which also 
contains five other genera: reovirus, orbivirus, phytoreovirus, fijivirus, and the 
cypoviruses72，i35. The Reoviridae are non-enveloped viruses consisting of a 
double-shelled icosahedral nucleocapsid with a diameter of 60-80 nm'^^. The 
capsid contains either 10，11，or 12 double-stranded RNA (dsRNA) segments 
for the reovirus and orbivirus, rotavirus, and Colorado tick fever virus 
resp)ectivelyi35 xhe viruses carry several enzymes including the RNA 
dependent RNA polymerase used during transcription. Transcription results in 
the synthesis of mRNA from each of the segments which is then used either for 
translation or as a template for the synthesis of the negative sense RNA to form 
dsRNA. Replication and assembly take place in the cytoplasm and often result 
in the formation of viroplasm and inclusion bodies'^^. 
Rotavirus is a major etiological agent of severe gastroenteritis of infants 
and young children. The virus was first reported during 1973 in duodenal 
biopsy specimens obtained from infants and young children with acute 
gastroenteritis using thin-section electron microscopy'^ Rotavirus was later 
detected in faecal samples from infants with diarrhoea using negative-stain 
electron microscopy^®'Before the discovery of the human virus, a filterable 
agent causing severe diarrhoea in calves had been identified in 1943 and was 
subsequently shown to be a rotavirus Rotavirus was also retrospectively 
identified as the causative agent of epizootic diarrhoea in infant mice (EDIM)^ 
reported in 1963. A virus causing severe diarrhoea in calves was named 
Nebraska calf diarrhoea virus (NCDV) in 1969, and also subsequently shown to 
be a rotaviruses�. Epidemiological studies have now demonstrated that rotavirus 
is the single most important cause of acute gastroenteritis in young children and 
in a wide variety of animals worldwide^ '^''^ ''^ '^^ ^^ In addition to human infants 
and young children human rotaviruses (HRV) also cause symptomatic infection 
in institutionalised adults over 60 years of age^ ^^ '^ ^ and chronic infection in 
immunodeficientpatients2�8’2!9’23 丨，284. 
Rotaviruses have been identified in most animal species examined, but 
they are of particular significance in commercially reared animals such as 
calves, pigs, lambs, and poultry which may suffer severe or even fatal diarrhoea 
155.180,244,260^  Morbidity among infected calves may reach 30-78% in herds and a 
morbidity of 26% has been reported among piglets52’i55’i62a’i67’234 Rotaviruses 
are thus of great economic significance in both humans and animals. 
1.2 General characteristics of rotavirus 
Members of the genus rotavirus are generally characterised by the 
possession of 11 dsRNA segments and a double capsid structure. There are nine 
morphological and biochemical characteristics that the virus should generally 
possess72’77，i35，i36 几^ se are as follows: 
1: Mature virus particles are non-enveloped and possess a core enclosed within 
a double-layered icosahedral protein capsid. Infectious virions (70 nm) 
possess an outer capsid with a sharply defined circular outline. The virus 
particles with a smaller diameter (60 nm), lack the outer capsid and have a 
rough outline surrounding the icosahedral nucleocapsid core (38 nm). 
2: The viral genome contains 11 dsRNA segments. 
3: The virions contain an RNA-dependant RNA polymerase for replication and 
additional enzymes responsible for the capping of the RNA transcripts. 
4: The virus replicates in the cytoplasm. 
5: The virus is capable of genetic reassortment in mixed infections with two or 
more strains. 
6: In vitro cultivation of rotavirus is facilitated by proteolytic cleavage of the 
outer capsid protein VP4. 
7: Mature particles are formed whilst budding through the rough endoplasmic 
reticulum (RER) where the virus acquires a transient lipid membrane. 
8: The virus has a lytic life cycle. 
9: Antigenic cross-reactivity detected within serogroups, A to G. 
1.3 Clinical and epidemiological characteristics of rotaviral infections 
1.3.1 Clinical features of rotavirus infection 
Clinical features of rotaviral diarrhoea have been studied in detail^ '^^ '^^ ^ .^ 
Children infected between the ages of six months to two years exhibit classical 
symptoms of viral gastroenteritis. Symptoms develop after an incubation period 
of one to two days and may last for two to eight days. These include diarrhoea 
with large volumes of watery stools, as well as dehydration, fever, vomiting and 
abdominal cramps. Respiratory symptoms may sometimes be present but it is 
unknown whether HRV is responsible for these86’丨56. Severe dehydration with 
associated electrolyte imbalance may lead to death, if appropriate rehydration 
therapy is not instituted in time^^ 
1.3.2 Nosocomial rotavirus infection 
HRV is one of the major causes of hospital-acquired infection in 
neonates and young children^ '^^ ^®. This is probably due to the large numbers of 
virus particles produced in faecal samples, their resistance to inactivation and 
their stability in the environment'^ '^''^ ®'^ ^^ In a study of 385 infants with 
rotavirus diarrhoea, 75 (19%) were nosocomial in origin . Hospital-based 
studies have shown between 17 to 33% of hospitalised children can acquire 
nosocomial HRV infection^ '^^ '^^ '^ ^^ A previously reported outbreak of HRV 
infection in the Special Care Baby Units ofPWH had demonstrated the need for 
rapid diagnosis and effective isolation procedures to prevent the spread of 
infections^^ 
1.3.3 Morbidity and Mortality of rotavirus infections 
1.3.3.1 Seasonal distribution of rotavirus in temperate regions 
In temperate climates HRV infection exhibits seasonal distribution, 
being most prevalent during the winter months of the year^ '^^ ^ '^^ ^ .^ A study in 
the USA did not find HRV during the summer but the virus accounted for 67% 
and 56% of diarrhoea cases during winter and spring, respectively. The 
relatively low humidity in these temperate regions during cooler months may 
increase the ability of rotavirus to survive in the environment leading to an 
increase in incidence of infection. However not all epidemiological findings 
have been consistent with that hypothesis and some parts of the world rotavirus 
infections show different seasonal distributions丨47，丨52，i85，24’58，68. 
1.3.3.2 Rotavirus infections in developing countries 
In less developed countries rotavirus is one of the major causes of fatal 
infant diarrhoea. The World Health Organisation has estimated that diarrhoeal 
disease is responsible for a large proportion of all deaths (15-34%) in 
developing countries^^^ An analysis of selected studies estimated that 744 
million to one billion episodes of diarrhoea with 4.6 million deaths per year 
occur in children less than five years of age in Africa, Latin America, and Asia 
(excluding China). An estimated 125 million of these diarrhoeal cases are 
attributed to rotavirus infection. Eighteen million of these were considered 
moderate or severe leading to 873,000 deaths in children one to four years of 
agei32. In this study rotavirus infection was reported in 34% of cases of infants 
under 18 months of age which had life-threatening diarrhoea'^l Malnutrition is 
thought to be an important factor which increases the clinical severity of 
rotavirus infections^^'^^^ 
1.3.3.3 Rotavirus infections in developed countries 
In developed countries diarrhoeal diseases are not associated with high 
mortality because better medical facilities and supportive treatments are 
available. However, it was found in the Cleveland Family Study in the USA that 
non-bacterial infectious gastroenteritis was the second most common disease 
experienced within family groups and accounted for 4,000 (16%) episodes of 
illness over a ten year period^^. A study in the USA reported 5539 children aged 
between one month and four years had died from diarrhoeal diseases between 
1973 and 1983^^^ The incidence of rotavirus infections in developed countries 
is probably as high as in underdeveloped countries but the morbidity may differ 
due to differences in sanitation (infecting dose) and mutation28’i7i. Studies in the 
USA, Australia, Japan, and the United Kingdom showed 34.5%, 52%, 45%, and 
52%, respectively, of patients hospitalised with acute diarrhoea, caused by HRV 
infection 職 i47，i56. 
1.3.4 Host resistance to rotavirus infection 
A number of factors are thought to be effective in protecting against HRV 
infection in infants. These include maternal antibodies acquired transplacentally 
and secretory IgA antibodies ingested through breast milk. Significant non-
immunological factors include good nutritional status2i’26’6i’245’2oo jntestinal 
mucins have been shown to inhibit HRV binding by preventing virus-cell 
attachment^�. Mucins in human milk have also been shown to inhibit rotavirus 
replication. Variations in milk mucin content may explain its variability in 
preventing infection285. It is likely that all these factors are involved, but their 
relative importance has not yet been established. 
Many studies using animal models have been reported on the importance 
of systemic and local immunity25’27’69，i6i’245’200 ^^s demonstrated that 
mucosal immunity, with the presence of coproantibody, is thought to be the 
major determinant in the prevention or the reduction of the severity of HRV 
diarrhoea203，ii9’i72 production of virus neutralising antibody is predominantly 
homotypic and directed against both outer capsid proteins, VP4 and VP7 
124,125,162,197.203,274,195^  Since VP7 and especially VP4 share one or more 
neutralising epitopes between rotavirus serotypes, heterotypic responses are also 
produced to a lesser extenti62’i65，2H253 Following a second challenge 
heterotypic immune response usually results in infections that are asymptomatic 
or of reduced severityi8，3i’34’245 presence of serum antibody is not 
necessarily indicative of protectioni4，273，47，although protection appears to 
correlate with high levels of circulating antibody^^'^^^, this is thought to be due 
to the associated presence of intestinal secretory antibody, and the transfer of 
circulating antibody to the intestinal lumen by transudation^^'^^'^^^'^^l 
Reinfection of adults is common when in contact with infected infants but is 
usually subclinical^^'. Institutionalised geriatric patients whose immune systems 
have been compromised with age are at greater risk of developing symptomatic 
HRV infection. Where underlying disease is present the infection may be 
critical. 
Neonates have been shown to be resistant to severe HRV infection and 
such infections are often asymptomatic. A high litre of transplacentally-acquired 
antibody and the qualitative or qualitative differences in the intestinal enzymes 
may be responsible for the reduced virulence observed in neonates^ '^^ ^^. The 
outer capsid protein VP4 gene in strains causing asymptomatic infections in 
neonates was found to be highly conserved in these strains^ '^^ ^. As no 
relationship between these strains has been established for the other outer capsid 
protein VP7, it is thought that this gene (VP4) may be associated with natural 
1.3.5 Pathogenesis 
Rotavirus infects mature epithelial cells of the upper small intestine, 
usually the jejunum. Studies on biopsies from infants and young children have 
identified morphological changes such as swelling followed by denuding and 
flattening of the epithelial The glucose-coupled sodium transport of the 
intestine is impaired due to the lysis of mature enterocytes and the immature 
crypt cell replacements are incapable of performing this function. This results in 
the reduction in the uptake of sodium and water, leading to isotonic 
dehydration. A reduction in the levels of disaccharidases, such as maltase and 
lactase, may also result in osmotic diarrhoea72，i36’i35 The progression of 
rotavirus infection within the gut has been described in gnotobiotic colostrum-
deprived calvesi35，as morphological changes in infants and newborn animals is 
similar it is likely the progression of infection will also be comparable. 
Following intraduodenal administration of rotavirus, infection of the small 
intestine takes place progressing from the upper to the lower small intestine. 
Morphological changes were apparent in 30 minutes at the site of infection. 
HRV takes about seven hours to reach the lower small intestine and by forty 
hours following the initial inoculation the small intestine appeared relatively 
nonnali35. 
1.4 Vaccine development for rotavirus protection 
As stated above, the World Health Organisation has estimated that in 
developing countries 873,000 infants under four years of age die from rotavirus 
diarrhoea each year^^ .^ It is therefore, very important that an effective vaccine 
be introduced to prevent this huge loss of life. In addition a vaccine would help 
reduce the morbidity caused by rotaviral diarrhoea in both developing and 
developed countries24，58’i32,i47,i56 p^^j. approaches are being taken to develop a 
vaccine against HRV infection. 
1.4.1 Attenuated HRV as candidate vaccines 
From studies of host resistance, live rather than killed vaccines, are more 
effective at inducing a high level of secretory IgA with mucosal immunity'^ 
Ideally a candidate vaccine's efficacy should approach that of a natural infection 
which was reported to be Cold-adapted HRV mutants that fail to 
replicate appreciably in the host can elicit a protective immune responsei75. 
However, these may revert to wild type and lead to severe disease, and are 
therefore considered unreliable. Asymptomatic 'nursery' strains may be 
naturally attenuated^ '^^ ^. These are currently under investigation as candidate 
vaccines, with certain studies showing no severe reinfection in vaccinees during 
the first two y e a r s ' O t h e r s studies have shown that these strains may cause 
severe diarrhoea suggesting that the reduced virulence of the virus may not be 
due to natural attenuation but to host resistance^® .^ 
1.4.2 Animal RV candidate vaccines (Jennerian approach) 
Animal RV are antigenically related to human strains and hence are able 
to elicit neutralising antibody against HRV with diminished virulence^ 
Two Bovine and one Rhesus RV (RRV) s t r a i n s ^ h a v e 
undergone clinical trials as candidate vaccines. 
Bovine RV RIT4237 (serotype 6) demonstrated good efficacy in the early 
stages265 but was later shown to be less effective in developing countries^ 
Multiple doses were required to illicit a protection rate of 58-75%268. The 
vaccine was particularly effective against serotype 1 but less so against serotype 
2. These data underscored the importance of using vaccines against multiple 
serotypes and also showed the requirement of multiple d o s i n g ^ B o v i n e 
RV WC3 (serotype 6) was shown to confer homotypic and heterotypic 
immunity in studies from the USA12’13，48 Rhesus RV MMU18006 (serotype 3) 
is immunogenic in vaccinees and illicits a good response against serotype 3 
infections but less so against serotype The vaccine was associated with 
mild side effects such as mild fever and watery stool and is currently 
undergoing further trials '^^ ^ .^ To date all these studies failed to recognise the 
ability of VP4 to illicit protective immunity. It is also thought VP4 is capable of 
inducing higher levels of rotavirus-specific neutralising antibodies than VP7i94a. 
It is necessary to consider both outer capsid proteins if an effective vaccine is to 
be developed. 
1.4.3 Intra and interspecies reassortants vaccine strains 
HRV/RRV (human x simian) reassortants which carry the HRV outer 
capsid genes VP7 and VP4 are currently under investigation as potential 
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vaccines Rhesus rotavirus-based quadrivalent vaccine candidates have also 
been introduced into phase III trials to identify a safe and optimally antigenic 
formulation—. Mouse dams, calves, gnotobiotic piglets, and humans orally 
immunised with reassortants of VP4 gene from one strain and the VP7 gene 
from the other, were shown to confer passive protection to progeny against 
challenge with either parental strain丨丨3，183，丨84 Protection was identified as a 
failure to develop symptoms or shed virus on challenge with a wild 
Vimsl97，241，247. 
1.4.4 Passive immunisation 
It has been shown that passively acquired neutralising antibodies to VP4 
and VP7 of rotavirus conferred resistance to disease in infant mice^ '^*'^ ''^ .^ A 
neutralising mAb directed against VP4 of Po/OSU strain also neutralised 
heterotypic Si/RRV and Bo/UK strains. Cross-reactive antibodies against VP4 
have also been shown to protect suckling mice passively against challenge by 
either homotypic or heterotypic HRV66. Based on these observations, it is 
possible" to prevent HRV infection passively, by the administration of specific 
neutralising antibodies. 
Variable results have been reported in studies investigating breast feeding 
and rotavirus infection in which it was reported that breast-feeding was 
beneficial in preventing rotavirus infection'^ '^^ '^" '^^ ®''^ '^  While others showed 
no difference between breast-feeding and formula feeding groups')). The 
variations in the content of mucins in milk may also help account for the 
variability in results experienced with breast feeding'^ "'. Bovine milk 
immunoglobulins were shown to confer passive immunity in in fan ts�� 
Colostrum containing high levels of antibody have been successful in 
controlling HRV in immunocompromised patients undergoing bone marrow 
transplantsi59，23i. 
1.5 Laboratory diagnosis of rotavirus infections 
1.5.1 Detection of rotavirus 
The diagnosis of HRV has an important impact on patient management. 
Identifying a rotavirus in such patients rules out the differential diagnosis of 
bacterial infections, allows for the appropriate treatment regimes and leads to 
the institution of infection control measures to prevent the spread of the virus. 
Clinically relevant rotavirus diagnosis is currently accomplished either by the 
direct detection of the virus by EM or the detection of the virus antigen by 
immunospecific tests. Propagtion of the virus in cell culture is feasible but is 
more commonly used in a research setting, as are molecular approaches. 
1.5.2 Negative stain electron microscopy (EM) 
Electron microscopy was instrumental in establishing rotaviruses as an 
etiological agent of infantile diarrhoea^^''^^. During the course of rotavirus 
infection, large numbers of virus particles are shed in the stool allowing for the 
direct visualisation of rotavirus particles in up to 90% of all positive cases. The 
sensitivity of the EM diagnosis can be augmented by concentrating the virus in 
the stool extract by ultracentriftigation. Moreover, electron microscopy allows 
for the detection of non-group A rotaviruses and other gastroenteritis viruses. 
Typing of rotaviruses directly from stool samples has been reported using 
serotype-specific antisera in solid-phase immuno-EM (SPIEM)^". However, EM 
suffers from the limitations of expensive equipment, need for highly trained 
technologists and the inability to automate the system to process larger 
quantities of specimens. 
1.5.3 Immunological assays for the detection of rotavirus antigens 
Immunological assays using specific antibodies to detect rotavirus 
antigens in faecal specimens can be readily set up and are available 
commercially 138. Methods commonly used include radioimmunoassays (RIA), 
enzyme-linked immunoassays (EIA) and latex agglutination''''^^. Rapidity, 
simplicity, sensitivity, and the ability to screen large numbers of samples arc the 
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major advantages of these assays over direct EM. Serological assays have also 
been developed to identify group B and C rotavirus??. EI A methods do have 
several disadvantages, Rotazyme II (Abbott,USA) cross-reacts with meconium 
in the gut of newborns requiring confirmation with latex agglutination. For 
typing there are difficulties in the standardisation of the methods and a lack of 
availability of monospecific antibodies directed against the less common human 
VP7 serotypes and against VP4 serotypes. The loss of the outer capsid proteins 
also prevents the typing of rotavirus by immunological assays. 
1.5.4 Polyacrylamide gel electrophoresis (PAGE) of rotavirus RNA 
The segmented dsRNA genome has allowed for the development of RNA 
electrophoresis as a diagnosis tool. This technique provides a simple 
inexpensive method by which to visualise the characteristic electrophoretic 
migration (4:2:3:2) pattern (electropherotype), of the Group A rotavirus dsRNA 
segments38’H7 (appendices A3.l-A3.il) when silver staining is used to detect 
the fragments, this method is a specific, fast and sensitive technique that can 
identify both group A and non-group A rotavirus^o?. The relative migration of 
individual dsRNA, namely the electropherotypes, segments remains constant 
For a given virus strain. The high degree of diversity of rotaviruses at the 
electropherotype level provides a valuable means for strain identification when 
monitoring the epidemiology of HRV and tracing nosocomial 
infections73’76’77’220 However, electropherotypes have no evident relationship 
with serological classifications^', except for HRV where short and long 
electropherotypes are generally associated with Subgroup I and II’ respectively. 
Though with the exception of two strains with identical electropherotype but 
different genotype" in most cases a single electropherotype corresponds to a 
single sub-type or 
1.5.5 Nucleic acid probe hybridisation assays 
Hybridisation of labelled single-stranded RNA transcripts^'^' 
CDNA130’i54’158’i9i ^^ type-spccific oligonucleotide probes^^ to heat denatured 
rotavirus RNA or cDNA immobilised on nitrocellulose or nylon membranes 
provides a highly sensitive and specific technique which has been used for the 
detection of rotavirus in faecal specimens and classification of rotavirus into 
groups, genotypes and genogroups. 
1.6 Antigenic classification of rotaviruses 
1.6.1 Rotavirus groups 
The complex classification of rotaviruses developed over a long time 
period. The primary division is that of the group and is based on immunogenic 
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epitopes carried on the major inner capsid protein (VP6) . Group antigens are 
determined by serological assays, such as immunofluorescence and EIA. Seven 
distinct serogroups (A to G) have been identified to date^^. 
Group A RV causes acute gastroenteritis in infants and young animals 
72，278. Rotavirus that lack group A and subgroup epitopes and possess unusual 
electropherotypes are classified as non-group A Group B viruses have 
been recovered from humans, pigs, cattle, sheep and rats^'''^^. They have been 
implicated as the cause of several large Chinese outbreaks of severe 
gastroenteritis in a d u l t s G r o u p C viruses have been isolated from humans, 
pigs and f e r r e t s T h e r e have been few human strains isolated, however 
reports of such strains have come from several countries^'^^ Groups D, F, and G 
have been recovered from c h i c k e n s ^ a n d Group E from pigs^ '^^ .^ The 
importance of non-group A RV as human pathogens outside China, has yet to 
be established^^. Additional epitopes common to each group can be found on all 
structural proteins 丨 35. 
1.6.2 Rotavirus subgroups 
In Group A rotaviruses, additional antigenic diversity on the trimeric 
form(川’()()of the inner capsid protein VP6 have revealed at least two distinct 
subgroup epitopes (subgroup I (S,) and II(S,|)). Most epidemiological studies 
indicate that subgroup II is predominant in HRV infections . All animal 
strains, except one lapine and three porcine strains, belong to subgroup 严’卯,!!。 
There are also strains with both'^'' or neither^ '^ ^ of the subgroup epitopes. An 
independent epitope, which resembles Sn, has been found on the core protein 
1.6.3 Rotavirus serotypes 
HRV are further classified into serotypes, by plaque reduction or 
fluorescent-focus reduction neutralisation assaysi98，i97’64b，279 These assays use 
sera from animals hyperimmunised with purified virus particles and are reactive 
with the two outer capsid proteins (VP4 and VP7). The glycoprotein VP7 
induces a stronger neutralising antibody reponse possibly because it forms the 
largest proportion of the vims' outer capsid. In the hyperimmune serum more 
type specific activity is directed to VP7 epitopes than to VP4 epitopes, possibly 
due to a loss of VP4 during preparation or storage of the virus antigen. 
Serotyping to date is based on VP7 and is defined with mAbs directed against 
VP7 specific epitopes. To date 14 distinct serotypes have been identified (see 
Table 5). The characterisation of the virus has been greatly simplified by a 
method of typing the VP7 protein directly from faecal material with a 
mAb-based EIA'^^. 
The difficulties of serotyping VP4 with hyperimmune antisera due to the 
predominance of VP7-specific antibody, have been overcome by preparing 
antiserum against baculovirus-expressed Other methods for typing 
based on the VP4 have involved hybridisation with specific probes and nucleic 
acid sequencing techniques. These have identified at least seventeen VP4 types, 
eight of which occur in humans, but .only three of these are frequently 
detected'^l 
There is no broadly accepted system to classify rotavirus but one proposed 
at the International Congress of Virology, Edmonton, Alberta, 1987 suggests 
the use of a cryptogram to convey the following information: 
group/species/place of origin/strain designation/year/subtype antigens. A single 
letter would be used to signify each independent antigen, for example P denotes 
the protease sensitive outer capsid protein VP4, G denotes the outer capsid 
glycoprotein, and the subgroup antigen would be abbreviated to S丨 or S^. If 
applied to the standard rotavirus strain Si/SAll the result would be 
A/Si/Africa/SAl l/58/G3,P2,S,; which could be abbreviated to A/SAl 1/G3,P2,S,. 
It is important that the system finally adopted should be standardised by an 
international committee to facilitate scientific communication and the 
production of standard reagents^^. 
1.6.4 Rotavirus genogroups 
Three genogroups of HRV have been determined by subgroup specificity, 
10Q 1 on 
electropherotype and by RNA-RNA hybridisation ’ . Most human strains are 
subgroup II and possess long RNA patterns and fall into the genogroup defined 
by the strain Wa (Gl,P8,Sn). Subgroup I viruses tend to possess short RNA 
patterns and fall into the genogroup defined by the strain DS-1 (G2,P4,Si). The 
least common strains belong to the category defined by AU-1 (G3,P9,Si), 
subgroup I with long RNA p a t t e r n s T h i s genogroup includes the serotype 
12 strains L26 and L27, which are thought to be of animal origin, resulting from 
VP7 reassortment between genogroups^"''*^'''^^. G8 strains bear limited 
homology with the short G2 strains but classification into the DS-1 genogroup 
is ambiguous204. 
1.7 Molecular biology of rotavirus 
1.7.1 Rotavirus genomic organisation 
Rotavirus is the only member of the Reoviridae family to possess eleven 
segments of dsRNA. For the simian strain SAll the genomic segments range 
from 667 base pairs (0.2 xlO^ Da) for segment 11 to 3,302 base pairs (2.2 xl(/) 
Da) for segment 1, with the total number of base pairs approximately 18,522 
and an estimated molecular weight of 11-
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1.7.2 Gene coding assignments 
A general agreement has been achieved on the coding assignments of 
rotavirus proteins (Table However, comparative studies have shown that 
variation in the absolute order of cognate genes may occur among different 
strains. The gene segment for the glycoprotein VP7 can be found on either 
segment 7，8 or 9 (S7 - some Si/RRV strains, S8 - Hu/DSl., S9 - HuAVa). In 
short electropherotypes, gene segment 11 coding for NS26 migrates more 
slowly than segment 10 coding for NS28. The identification of the gene must 
therefore be based on specific hybridisation probes, reassortment analysis, 
biochemical or immunological analysis of protein synthesised from gene 
specific mRNA, in vitro translation (cell free translation system) and sequence 
analysis of ds or ssRNA?:’丨 12. 
1.7.3 Genome and protein structure of rotavirus VP7 
The gene segment coding for this glycoprotein (34.6-37.1 KDa) may be 
located on one of three gene segments, depending on the strain analysed'^'^^. 
VPTwhich exists as a dimer is the major outer capsid protein and the second 
most abundant viral protein (30% of VP7 is highly immunogenic and 
is the antigen against which most neutralising antibodies are directed^" .^ 
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Rotavirus gene coding assignments (Si/SAll) 
Protein Gene Segment Size (BP) 
Outer Capsid VP4 (VP5* + 
VP8*) 
4 2361 
VP7 9 1062 
Inner Capsid VP6 6 1356 
Core VPl 1 3302 
VP2 2 2587 
VPS 3 2591 
Non-Structural NS53 5 1581 
NS35 7 1059 
NS34 8 1104 
NS28 10 751 
NS26 11 667 
There are two conserved initiation codons at nt49-51 and 136-138. The 
second “ in frame initiation codon possesses the stronger initiation sequence 
based on Kozak's rulesi4()，7(). Both initiation sites are used, producing two 
primary translation products of 37 KDa and 35.3 KDa''^ These proteins are then 
modified by cleavage to form the same final producr'^^ It is unknown why the 
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first and weaker initiation codon is conserved. The larger of the two VP7 ORFs 
contains 978 nucleotides or 326 amino acids丨�’23，64’94’丨27,282 and the smaller is 30 
nucleotides shorter, 316 amino acids in length''^ 
The initiation codons precede the conserved regions of hydrophobic 
amino acids (HI and H2 absent in the final protein). Region H2 is thought to be 
the cleavable signal sequence that directs VP7 to the RER where it is 
maintained as an integral membrane protein with luminal orientation, using two 
regions at residues 51-61 and 62-lll2i3’246. ypy appears to be the protein 
responsible for the attachment of the virion particle to the host cell to initiate 
infectio,，曜 8. 
In group A rotavirus serotypes have been identified by reciprocal 
neutralisation tests with hyperimmune sera, of which seven (serotypes 1 - 4, 8, 
9，and 12) are usually found in humans^l The amino acid sequences obtained 
for group A serotypes show significant homology within the serotype (91-
100%), but conservation between serotypes is greatly reduced (<71%). Nine 
regions, with six (regions A to F) possessing type-specific sequences^'^''''^''^^ in 
the linear amino acid sequence are highly divergent丨肌”)^  (Table 2, Fig I). 
Sequence homology of VP7 variable regions within serotypes, and low 
homology between serotypes especially regions B (VR-5), D (VR-7), and E 
(VR-8) (51-67%) enable the sequence of the gene 9 segment to be used to 
Table 2 - Location of variable regions on the outer capsid glycoprotein VP7 
Variable region 
(VR) 
amino acid no. 
(serotype-specific regions) 
Amino acids involved 
in neutralisation 
escape 
1 9 - 20 + 
2 25 - 32 + 
3 ( A ) 37 - 53 
4 65 - 76**X 
5 ( B ) 87 - 100* 94,96,99,(104) 
6 ( C ) 119 - 1 3 2 " 
7 ( D ) 141 - 150*X 145,146 
8 ( E ) 208 - 224*X (201),211,213, 
217,221,(291) 
9 ( F ) 235 - 242**X 
VRl-3 are removed from the final product by cleavage (aal-50) 
• ‘ 1. ‘. 101,164,194,254 
* - neutralisation epitopes 
** possibly an important neutralisation epitope—’⑴！ 
+ hydrophobic region 
X hydrophillic region 
(aa) - found in constant region 
references 65,94,96,108,109,114,146,218,222,254 
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Figure 1 - Major capsid protein VP7 
highlighting locations of variable and 
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predict the serotypeiio’255. VR-E of serotype 3 appears to be similar to that of 
serotypes 8 and 9 as several neutralising monoclonal antibodies (N-mAb) were 
cross-reactivei45’i28. Sequence analysis of the VR-E region revealed only a 
single amino acid difference (residue 213 Asn for Thr) between these serotypes. 
This homology is too great to classify these viruses as an individual serotype 
however, when two or more regions were considered then the homology falls to 
82.8% (with VR-5) below the cut-off of 85% which is required to define a 
serotype丨08. These regions may show less divergence between serotypes, but, 
with the exception of VR-E, regions conserved between serotypes have not 
been observed'®^ Since all six VR in the mature protein are conserved within a 
serotype this suggests they are important collectively in defining serotype-
specificity, probably by maintaining the conformational structure of the VP7 
and its epitopes'^ '^ '^ ''''^ '''^ '^^ ^ .^ Selective pressure may cause divergence from one 
serotype to another, though this is limited by combinations that maintain the 
requirements of the functional protein^'^l 
The variable regions 5 (B), 7 (D) and 8 (E) are the exclusive regions in 
which single amino acid substitution produces escape mutants resistant to 
neutralisation by mAbs directed against Homotypic mAbs appear to 
select single amino acid substitution in VR-5, VR-7 and VR-8; with heterotypic 
mAbs selecting mutations only in VR-5. Two scrotype-specific (SI, S2) and 
three cross-reactive epitopes (C1-C3) have been identified. SI , S2, and C3 
overlap operationally, as do SI and CI whereas C2 is an independent 
neutralisation e p i t o p e O v e r l a p p i n g of epitopes indicates that a close 
structural and functional relationship exists between the cross-reactive and 
serotype-specific epitopes on A cross-reactive mAb capable of selecting 
mutations in both variable regions B and E suggests they form a single reactive 
domain. VR-D also appears to be related functionally to this domaini45，i46’i65,2:)4 
In strain Hu/Ku (Gl ) five neutralisation epitopes appear to overlap operationally 
to form a single large domain*^^. Conformation also appears to be important as 
N-mAbs do not recognise denatured ypy'^ ,^91,114,228 ^^ epitopes where 
conformation has been altered by glycosylation''^ 
Hydrophilic regions in the proteins are usually found with an external 
orientation in the tertiary structure. Being exposed to the hosts immune system, 
these regions often have a high degree of sequence variability'^^''^®. The 
variability of these regions result from immunological pressures selecting for 
viable mutants resistant to neutralisation^". Four hydrophillic regions that 
exhibit a high level of homology have been determined and these possibly 
correlate with common antigenic determinants⑴ ’42’94’96 
Rotavirus VP7 is an unusual virus glycoprotein in that it possesses N-
linkcd mannose oligosaccharides and not the complex oligosaccharides usually 
• Classification of strains based on the capsid protein VP7 
VP7 
Serotype 
Human Strains Animal Strains 
1 Wa, KU, RV-4, K8, M37，D, 
SI 2，Mont(MO) 




3 Ito, Yo, P, M, Nemeto, AU-1, 
RV-3，W178，PCP5’P1270, 
MZ58 
Si/SAll, Si/RRV:1, Si/RRV:2, 
Po/CRW-8, Po/MDR-13, 
Po/AT/76, Ca/CU-1, La/Ala, 
La/C-ll,La/R-2,Mu/EB, 
Eq/H-2, Eq/FI-14, Fe/2, Fe/3， 
Fe/22, Fe/97 
4 Hochi, Hosakawa, St. Thomas-




5 Po/OSU, Po/TFR-41, Po/EE, 
Eq/H-1 
6 #PA151,PA169 Bo/NCDV, Bo/UK, Bo/C486, 
Bo/Rf, Bo/WC3 
7 Ch/2, Ty/1? 
8 69M，B37, B38，HALU66 Bo/A5, Bo/678, Bo/J2538 
9 WI-61,F45，AU32， 
#Mc345,M673 








associated with enveloped viruses'"^. Glycosylated VP7 probably plays an 
important role when single-shelled particles bud into the lumen of the RER, 
acquiring the outer capsid protein VP7 and a temporary envelope^'. However, 
glycosylation is not essential for infectivity, as infectious mutants of SAll 
without glycosylated VP7 have been described^ The role of the 
structural glycoprotein is not fiilly understood, but it may help it stabilise the 
capsid227’248 There are four potential sites of glycosylation in rotavirus thus far 
analysed (Fig. 3)4W4.109,im, 127,218_ 丁^。site at Asn-69 in Si/SAl 1 is found in all 
rotavirus strains except Bo/NCDV and Bo/Rf. There are zero, one or two 
glyscosylation sites utilised, though which additional sites are used remains 
unknown. Glycosylation is an important factor for antigenicity. A single amino 
acid substitution at 211 producing a new glycosylation site within the VR-8 
region resulted in the mutation being resistant to neutralisation by hyperimmune 
antisera237. Glycosylation rendered the site inaccessible to neutralising antibody 
indicating that VR-8 is an immunodominant site on VP7 or sterically close to 
that site in the 3D structure^^. 
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1.8 Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) for 
genotyping of rotavirus 
The standard method for typing HRV has involved serological assays, 
such as monoclonal based EIA^ '^^ , immunofluorescence or fluorescent focus 
neutralisation a s s a y s 丨98，28o. There are several disadvantages to such approaches 
for typing HRV. Suitable type-specific monoclonal antibodies for the assay are 
difficult to abtain particularly for the less common human serotypes such as G8, 
G9, and These assays require the virus in the specimen to possess the 
outer capsid proteins, which may be lost during storage and therefore render the 
specimens The development of RT-PCR has had a major import 
in this area. 
RT-PCR is a powerful technique for the amplification of specific 
sequences of RNA. In this method the sample is first purified to remove 
inhibitors (see Fig. 4). The viral RNA is then transcribed to cDNA with the 
reverse transcriptase. The cDNA is then replicated by a temperature resistant 
Thermus aqiiaticus DNA dependent DNA polymerase (Taq polymerase). The 
sample is" denatured at 94°C following which the temperature then reduced to 
allow type/group specific primers to anneal to the single-stranded cDNA. The 
temperature is raised to allow for the primer to be extended producing a copy of 
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the template required. Repeated cycling results in an exponential increase in the 
number of cDNA copies (see Fig. 6 ). 
Based on the sequence analysis of the VP7 gene of strains of different 
known serotypes, nine regions of high variability have been identified among 
these. These regions show a high degree of homology within serotypes (91-
100%) (Table 2，Figs. 1 and 5) but not between serotypes (51-67o/o)職"o’iH255 
They are thought to collectively define type-specificity^^'^^'' Several 
regions, particularly the major neutralisation epitopes VR-B，VR-D, and VR-E, 
are thought to overlap, suggesting type-specificity may be determined by 
conformation丨45’丨46，丨65，254 However，genotyping differs from serological typing 
in that the target of the assay is the gene that codes for the capsid protein rather 
than the protein itself. These factors suggest that genotyping may not directly 
reflect the antigenicity of the virus as determined by the immune response to the 
VP7 within the host. 
The 5丨-and 3丨-non-coding regions are highly conserved (Appendices 
A4.1-A4.8), and are suitable sites to direct primers to synthesise a full-length 
copy of the VP7 gene for the majority of RV strains. The primers for the RT are 
then used to amplify the flill-length cDNA by PGR. By designing type-specific 
primers to anneal to individual variable regions on the VP7 cDNA, the product 
will be of a specific size for a given genotype. The product size can then be 
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determined by electrophoresis, with suitable size markers, and hence allowing 
the genotype specificity to be deduced (Figs. 5 and 7，Table 5). These methods 
correlate with enzyme immunoassays but have better sensitivity. They have 
been used to identify groups A to C, and to identify virus types based on genes 
for VP4 and VP7 of group A 尺 严 ， 丨 o — s 
1.8.1 Prevention of Contamination in RT-PCR 
PGR is capable of amplifying a single copy of target DNA. Therefore, a 
major concern about this methodology is its susceptibility to contamination 
from genomic RNA or cDNA during sample or RT-PCR preparation^^'. 
Contamination poses a major problem in laboratories with a long history of 
handling the virus concerned. This is especially true of rotavirus which has been 
shown to be stable in the environment with its dsRNA resistant to 
degradationi33’i40. Hence contamination may occur even on the absence of 
infectious particles. Three ways in which this may cause false positive results or 
the mis-typing of specimens include; sample to sample carry over; carry over of 
amplified DNA from previous PGR; and sample or product to RT-PCR reagent 
contamination. To minimise potential errors due to carry over several 
adopted. These include the physical separation of pre- and 
post-PCR procedures and performing the procedure in a laminar flow hood to 
reduce contaminating DNA by aerosols and to irradiate it by UV irradiation. 
Reagents should be aliquoted and stored in an area free from amplified 
DNA. By labelling each lot and recording the usage of reagents, it is possible to 
track down contamination. Positive displacement pipettes or filtered tips reduce 
contamination from pipettes to samples. Precautions in the handling of all stages 
from sample collection, preparation, and extraction help prevent cross-
contamination. These include the frequent changing of gloves, minimising the 
handling of samples, the addition of non-sample reagents prior to the addition of 
DNA sample, frequent cleaning of equipment and work area to remove nucleic 
acid, and also care to reduce the production of aerosols. Aerosols are 
particularly important sources of contamination as particles can be as large as 
20 |im in diameter (4x10'^ |il) and may carry 2.4x10'^  copies of an amplified 
sequence^^'. Appropriate controls should be included in each batch of RT-PCR 
and if any contamination is detected results should be repeated after 
decontamination. 
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1.9 - Objectives of the study 
In Hong Kong HRV has been shown to account for over 20% of all cases 
of infantile diarrhoea requiring hospitalisation and over 50% of cases during 
winter in Hong Kong^^ This study also identified the importance of HRV 
diarrhoea and noted the need for better understanding of rotavirus before 
treatments or vaccines can be developed to reduced morbidity. It will only be 
possible to understand the population dynamics of HRV in the community, such 
as the emergence of new or unusual strains/types and more frequently the 
succession of predominant strains/types, with continuous monitoring over an 
extended period of time. This study was designed as a continuation of work 
initiated by R. Chan for his PhD. thesis 'Epidemiology and genetic variation of 
rotavirus infections in Hong Kong38. This study utilised mEIA and 
oligonucleotide probe hybridisation for typing HRV. During this study several 
problems with the typing methodologies were identified. In addition to this the 
high degree of strain variability helped confirm the need for continuous 
surveillance to better understand the HRV. 
The first objective of this study was the introduction of a non-radioactive 
method for genotyping HRV with increased sensitivity and specificity. To 
overcome the problems associated with the conventional mEIA system for 
serotyping a reverse transcription-polymerase chain reaction (RT-PCR) method 
as described by Gouvea et al'^ ^ was adopted. 
The second objective of the study is to continue surveillance of HRV 
strains causing severe diarrhoea in Hong Kong. A great deal of work has been 
carried out to develop an effective vaccine to prevent or reduce the severity of 
rotavirus infections'*^'^The continuous monitoring of the HRV genotypes 
will help understand the evolution and the population dynamics of the virus. 
The ultimate goal is to determine the characteristics an effective vaccine must 
possess to reduce the mortality and morbidity resulting from HRV infection. 
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MATERIALS AND METHODS 
All reagents and solutions are listed in appendix 1 
2.1 Collection of specimens 
A total of 10,251 specimens were obtained from patients admitted to the 
paediatric wards at the Prince of Wales Hospital, Shatin with diarrhoea. 
Specimens were submitted to the Department of Microbiology from July 1985 
to April 1994 for the diagnosis of HRV infection. A direct solid phase enzyme 
immunoassay (Rotazyme II, Abbott Labs., USA) was used to detect rotavirus 
antigens in faecal specimens. HRV positive specimens were then stored at -
80°C. 
The work described in this thesis utilised the above specimens and the 
related hospital and laboratory records. Part of the above specimens had been 
studied previously under a more limited protocol, but has been included in this 
thesis, having been re-tested or examined by newer methods as necessary. 
Where results from the previous work were utilised, their source has been 
acknowledged. 
2.2 Standard rotavirus strains 
Eleven tissue culture adapted rotavirus strains were used as standards 
throughout the study, all were of human origin unless otherwise stated: Wa, 
KU, K8, and RV4 (serotype Gl, subgroup S„); S2, RV5 (serotype G2, subgroup 
S,); Yo (serotype G3, subgroup Sn), Simian SAl 1 (serotype G3, subgroup SO; 
Hochi (serotype G4, subgroup S,i); and Bovine UK and NCDV (serotype G6, 
subgroup Si). All strains were propagated in MA 104 (monkey kidney) cells and 
stored at -80�C. RV4 and RV5 were provided by R. Bishop, Royal Childrens 
Hospital, Parkville, Australia. 
2.3 Tissue culture techniques 
2.3.1 Growth of MA104 cell line 
Cells of the monkey kidney cell line MA 104 stored in liquid nitrogen were 
thawed rapidly in a water bath at 37°C, transferred to a 10 ml tube and pelleted 
by centrifugation (1500 rpm, 10 minutes). The cell pellet was then resuspended 
in Minimum Essential Medium (MEM) to remove any dimethyl sulphoxide 
(DMSO) re-pelleted centrifugation (150,0 rpm, 10 minutes). The pellet was 
resuspended in 1-2 ml MEM, transferred to a 75 cm^ culture flask, and after the 
volume was made up to 10-15 ml with MEM containing 10% FCS the cells 
were incubated at 37()C until a confluent monolayer was obtained. 
2.3.2 Subculturing of MA104 cell line 
MEM was removed from the culture flasks and the confluent cell 
monolayer was washed once with PBS. EDTA-trypsin (3-5 ml) was added for 
30 s and was then removed. The cells were incubated at 37°C for 5-10 minutes 
until they were noted to detach from the flask surface. 4 ml of MEM containing 
10% FCS was added and the cells completely dispersed. 1 ml of the cell 
suspension was then transferred to each new flask，the volume made up to 10-15 
ml with MEM containing 10% FCS and the cultures incubated at 3TC. 
2.3.3 Virus propagation and isolation 
The standard rotavirus strains were propagated in the MA 104 cell line in 
the presence of an activating agent (trypsin) in 75 cm^ flasks as previously 
described230. The virus inoculum was treated with 10 j^g/ml trypsin for 30 
minutes at 37�C. The MA 104 monolayer to be inoculated was washed twice 
with PBS to remove any foetal calf serum (FCS), which may contain anti-
rotavirus a n t i b o d y o r neutralise the trypsin. 5 ml of activated virus suspension 
was added to each 75 cm^ monolayer and incubated at 37�C for one hour to 
allow adsorption. To ensure even distribution of the virus the flask was rocked 
every 15 minutes. Excess virus was removed and the cells incubated in 15 ml 
FCS-free MEM, containing 0.5 yig/m\ trypsin at 37�C. Cytopathic effect (CPE) 
indicative of rotavirus infection was usually observed after 2-3 days. 
2.3.4 Harvesting and purification of virus particles 
After 70-80% CPE was observed in the cell monolayer, virus-containing 
cells were subjected to three freeze-thaw cycles and were pelleted by 
centrifligation at 5000 rpm for 20 minutes. The virus was extracted from the cell 
pellet with trifluorotrichloroethane (Freon with the virus being 
partitioned into the pink coloured aqueous layer. 
The free virus in the aqueous layer was pelleted by high speed 
centrifligation (22000 rpm, 3h, 4°C). The supernatant was then discarded and 
the pellet was resuspended in 4 ml PBS. The virus was then purified by caesium 
chloride gradient centrifligation. A starting density of 1.36 g/ml CsCl was use<d 
which is equivalent to 0.492 g CsCl per ml of viral suspension. Therefore, for 
approximately 4 ml of virus suspension 2 g of CsCl was required. The virus 
suspensed in CsCl was centrifuged at 40,000 rpm for 16 h at 4°C which formed 
a density gradient and the virus became concentrated as sharp bands at its 
respective buoyant density. Nucleic acid has a higher density than protein, as 
the proportion of nucleic acid increases the particle density also increases from 
pi.36 For the complete particlc to pi.38 for the single shelled particle to pi.44 
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of the viral core. The purified virus preparation was harvested by inserting a 
needle into the side of the tube and aspirating the pl.36 band. The fraction 
containing the pl.36 bands was resuspended in PBS and the virus pelleted by 
centrifligation at 22,000 rpm for 3 h at 4°C. The supernatant was discarded and 
the pellet of purified virus of each fraction resuspended in 1 to 2 ml of PBS and 
stored at -80°C. 
2.4 Rotavirus electropherotyping by PAGE 
The methodology was based on the protocol of Herring et a 
and Rodger and Holmes (1979严.The method consists of the 
described below. 
(1982)117， 
Approximately 50-100 mg of faecal sample or 100-200 \i\ 
infected MA 104 cells (2.3.4) was suspended in 500 |il of 0.1 M sodium acetate 
pH 5, 1% SDS. 500 |il of "phenol-chloroform" mixture was added and vortexed 
for 1 minute, followed by centrifligation at 13000 rpm (MSE, Microcentaur®) 
for 5 minutes. The upper aqueous layer containing the rotavirus dsRNA was 
then transferred to a fresh 1.5 ml microcentrifuge tube. The extraction procedure 
with phenol chloroform was repeated for a second time. The dsRNA was then 
stored at -20�C. This method is suitable for the preparation of dsRNA for 
polyacrylamide gel electrophoresis analysis. 
2.4.2 Polyacrylamide gel electrophoresis (PAGE) 
The discontinuous buffering system as described by Laemmli 1970* '^ was 
used, with the absence of SDS from all solutions. A 10% polyacrylamide 
separation gel, and a 3% polyacrylamide stacking gel were used. 15 |il of 
dsRNA in sample buffer were loaded per well and electrophoresis was carried 
out with a constant current (15 mA per gel) for approximately eighteen hours in 
a vertical electrophoresis system (LKB,Sweden). 
2.4.3 Silver staining ofRNA in polyacrylamide gels 
Following electrophoresis the gels were soaked in fixing solution 
(Al.2.11) for 30 minutes followed by 30 minutes in 0.01 IM silver nitrate 
solution (Al.2.12). Excess silver nitrate was then removed by washing with 
water and the dsRNA bands visualised by placing in developing (reducing) 
solution (Al.2.13) until the brown coloured bands appeared (5-10 minutes). 
After removal of the developing solution the reaction was stopped with 5% 
acetic acid (A 1.2.14). It was necessary to add the acetic acid slightly early to 
prevent over development of the gel as the bands continue to darken until the 
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acid penetrates the gel. The gel was visually examined and then photographed 
on a light box. 
2.5 Enzyme immunoassays in rotavirus typing 
2.5.1 Preparation of monoclonal antibodies from hybridoma cell lines 
2.5.1.1 Growth of hybridoma cell lines 
Vials containing the hybridoma cell lines were removed from liquid 
nitrogen and immediately immersed in H2O at 37°C to thaw the cells. The cells 
were removed and washed by transferring the contents to a 10 ml centrifuge 
tube, with 6 ml of growth medium RMPI 1640 containing 15% FCS. The cells 
were pelleted by low speed centrifiigation at 1500 rpm for 10 minutes, 
resuspended in 5 ml of the growth medium and then transferred to a culture 
flask in approximately 30 ml of medium. The hybridoma cells were grown at 
37°C in 5% CO2 with the cells gently resuspended by agitation daily until the 
medium became cloudy. The cells were then pelleted by centrifiigation at 1500 
rpm for 10 minutes and the supernatant recovered. The monoclonal antibodies 
were purified by precipitation from the supernatant with (see 2.5.4 
below). To prepare mouse ascitic fluid the cells were washed twice with RMPI, 
with no FCS prior to being injected into the mice. 
Table 4 - Subgroup and serotype-specific monoclonal antibodies 
Antibody Antibody Specificity 
255/60 # anti-subgroup I 
631/9 # anti-subgroup II 
60 # Anti-rotavirus serotypes 1-4 
5E8# Anti-rotavirus serotype 1 
2F1# Anti-rotavirus serotype 2 
159 # Anti-rotavirus serotype 3 
ST3:1* Anti-rotavirus serotype 4 
# Mouse hybridoma cell lines kindly provided by H.B. Greenberg, 
University, USA (refs 112,238,236) 
* Monoclonal antibody ST3:1 supplied by Silenus Labs., Australia 
2.5.1.2 Preparation of mouse ascitic fluid - monoclonal antibodies 
Male Balb/c mice were first primed by intra-peritoneal inoculation with 
200 \i\ Pristane (Sigma,USA) 10-15 days prior to injection with the hybridoma 
cell lines. Washed cells were then injected intra-peritoneally at a concentration 
of 2 X 10^ cells per mouse. The abdomen of the mice became swollen with 
accumulation of ascitic fluid one to three weeks later. The ascitic fluid was 
harvested by the insertion of a large gauge needle into the peritoneum. The 
pressure of the fluid allowed it to flow through the needle to be collected in a 
centrifuge tube. The fluid was clarified by centrifugation at 2000 rpm for 10 
minutes to remove the cellular components. The supematants were collected 
and stored at -20°C until used. 
2.5.2 Confirmation of Antibody activity by immunofluorescence 
2.5.2.1 Preparation of virus-infected cells 
Fifty culture tubes containing confluent monolayers of MA 104 were used 
of which nine tubes were infected with each of five standard rotavirus strains 
(Wa G1,S„; S2 G2,Si； Yo G3,S„; Hochi G4,S„; SAl 1 G3,Si) and the remaining 
five tubes were used as negative controls. For infection 0.1 \x\ of the trypsin-
treated vims was added to each tube followed by 1 ml of MEM, 0% FCS, 
containing 0.5 |ig/ml trypsin. The cells were initially incubated for one hour at 
37°C rocking every 15 minutes to ensure an even distribution of the virus. The 
cells were then incubated at 3TC in a roller drum until 70-80% CPE was 
observed. A cell suspension was then made by scraping the cells off the wall of 
the tube with a pipette. These were transferred to a centrifuge tube and the cells 
pelleted by centri(ligation at 3500 rpm for 9 minutes. The supernatant was 
removed and the cell pellet was washed twice with PBS. The final cell pellet 
was resuspended in 500 of PBS and spotted on slides for 
immunofluorescence assays. • 
2.5.2.2 Confirmation of serotype-specificity of the monoclonal antibodies by 
immunofluorescence microscopy 
The volume of infected cell suspension was adjusted so that a drop applied 
to the microscope slide resulted, on drying, in a confluent layer of cells. Slides 
on which virus-infected cells from each of the four HRV serotypes were dried 
were prepared. The cells were then fixed by immersion of the slide in ice cold 
acetone for 10-15 minutes and the slides were stored at 4°C until required. 
To each of the wells on the slide carrying the fixed infected cells, 15 |il of 
mouse type-specific monoclonal antibody suspension was added and incubated 
at 37�C in a moisture chamber for 30 minutes. The slides were washed three 
times with PBS. 15 }il of 1 in 20 dilution of the fluorescein conjugated rabbit 
anti-mouse antibody (Dakopatt,Denmark) was added to each well and then 
incubated for 30 minutes at 37°C in a moist chamber. After washing three times 
with PBS one drop of mounting fluid (Syva,USA) was applied and entire slide 
covered with a cover slip. The slide was viewed by a UV-light microscope. An 
apple green fluorescence within the cell cytoplasm is indicative of a positive 
signal and specific reactions with the panel of standard rotavirus strains was 
indicative of monoclonal antibody type-specificity. 
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2.5.3 Polyclonal hyperimmune antisera against rotavirus 
The hyperimmune polyclonal antisera were raised in guinea pigs against 
four tissue culture adapted strains Wa (serotype 1), S2 (serotype 2), Yo 
(serotype 3), and Hochi (serotype 4). The presence of the anti-rotavirus 
antibodies in the guinea pigs prior to immunisation was ruled out by indirect 
immunofluorescence microscopy. Fractions of CsCl purified double-shelled 
rotavirus particles (approximately 50 jig) were emulsified with equal volumes 
of Freund's complete adjuvant (Sigma, USA) and PBS (0.5-1.0 ml), and for 
subsequent injection with Freund's incomplete adjuvant (Sigma, USA) and PBS 
and sequentially inoculated intramuscularly at two week intervals. Serum was 
collected approximately two weeks after the final inoculation. 
2.5.4 Immunoglobulin purification 
To the clarified serum sample containing the anti-rotavirus 
immunoglobulin an equal volume of 36% sodium sulphate (Na2S04) was added 
to give a final concentration of 18% which leads to the precipitation of globular 
proteins. The preparation was incubated for two to three hours at 4°C to allow 
the precipitate to form. The precipitate was pelleted by centrifugation at 3000 
rpm for 30 minutes and the supernatant removed. The pellet was washed by re-
suspension in 18% Na2S04 and pelleted by centrifugation at 3000 rpm for 30 
minutes. This was repeated until the supernatant was clear. The pellet was 
dissolved in a small volume of PBS and dialysed in PBS at 4��overn igh t . The 
dialysed immunoglobulin was collected and the concentration of the protein 
determined, by spectrophotometer at wavelengths of 235 nm and 280 nm. 
Protein concentration (mg/ml) = rOD235 nm) - rOD280 n m � x dilution factor^^^ 
2 . 5 1 
2.5.5 Monoclonal antibody-based serotyping and subgrouping EIA (mEIA) 
( F i g . 2 ) 
The wells on a microtitre plate were coated with 100 |il of the optimal 
dilution of the polyclonal capture antibody (guinea pig polyclonal anti-rotavirus 
antibody) dissolved in carbonate buffer, pH 9.8. The optimal dilution was 
previously determined by checkerboard titration. The plate was incubated 
overnight at 4°C. Following the addition of each reagent and subsequent 
incubation the plate was washed five times with PBS-Tween. The blocking of 
unreacted sites was done by adding 1% BSA in PBS and incubating the plate at 
37()C for 1 h. To each well 100 i^l of a 20% stool suspension in PBS, 1% BSA 
was added and incubated overnight at 4"C. The optimal dilutions of the mouse-
monoclonal antibodies were previously determined. These were as follows:-
255/60 a-SI 1/128, 631/9 a-SII 1/128, 60 a-Gl-4 1/2000, 5E8 a-Gl 1/500, 2F1 
a-G2 1/2000, 159 a-G3 1/2000，ST3:1 a-G4 1/100. 100 of each optimal 
dilution was added to the plate and incubated at 37°C for 1-2 h. 100 j^ l anti-
mouse antibody conjugate was then added and incubated for 1 h at 37�C. Two 
different conjugates were used during the study namely horse radish peroxidase 
(HRP) (A 1.4.4) and b: alkaline phosphatase (AP) (Al.4.3). For HRP the 
reaction was stopped with 100 |il of 1 M H2SO4 and the optical density (OD) 
read at 492 nm using a quantumatic analyser (Abbott, USA). For AP the 
reaction was stopped with 50 2 M NaOH and the OD read at 405 nm. For 
both conjugates, the reference wavelength for the product was 650 nm. A 
sample was considered positive if the OD reading was greater than 0.2 and was 
more than twice as high as any other monoclonal antibody used for serotyping 
or subgrouping the same specimen. 
Figure 2 - Monoclonal based enzyme immunoassay for 
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2.6 Reverse Transcriptase-Polymerase Chain Reaction genotyping of 
rotavirus (RT-PCR) 
2.6.1 Primers used in RT-PCR 
Eight primers (Table 5) were synthesised with the Cyclone plus DNA 
synthesiser (Millipore，UK), following the manufacturers protocol, with 
sequences obtained from a previous study by Gouvea'®^. 
2.6.1.1 Preparation of oligonucleotide primers for rotavirus genotyping 
The Cyclone plus DNA synthesiser utilises the beta-cyanoethyl 
phosphoramidite method, with synthesis carried out on a solid support, 
derivatised with the initial protected 3’ nucleoside contained in a reaction 
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column. The synthesiser adds each successive protected nucleotide monomer 
(phosphoramidite) following a series of steps a: detritylation; b: activation; c: 
coupling; d: oxidation; and finally e: capping. After each step the column is 
washed to remove excess reagent and reaction by-products. In the synthesis of 
each of the eight oligonucleotide primers, the final 5'-Dimethoxytrityl (DMT) 
group (cap) was not removed so that the oligonucleotides could be purified by 
an affinity column (Oligopack column, Millipore). 
2.6.1.2 Detachment of the primer from the column 
Utilising two syringes attached to either end of the column containing the 
primer, 5 ml of fresh 30% ammonium hydroxide was passed through the 
column back and forth four times and the column incubated in the dark for 45 
minutes. The passage and incubation with the ammonium hydroxide was then 
repeated twice and the ammonium hydroxide now containing the primer was 
incubated overnight in an air-tight container in the dark. The removal of the 
primer from the column and deprotection of the phosphorous by p-elimination 
of the cyanoethyl group required only 90 minutes. The acetyl capping groups 
and base protecting groups required a longer period. The overnight incubation at 
room temperature minimised cletritylation and so increased yield. A 100 
aliquot was removed and its OD260 determined in order to calculate the yield. 
2.6.1.3 Purification of the oligonucleotides 
Separation is based on differences in the relative hydrophobicities of the 
different species in the solution. The more hydrophobic the species the longer it 
is retained in the column. The presence of the 5'-DMT group means the 
incomplete sequences with the 5丨-hydroxy group, are eluted before the 5丨-DMT 
primer. Absence of the DMT-group means these failure sequences, with the 5'-
hydroxy group, are eluted first. 15 ml of acetonitrile was passed through the 
"oligo-pak" column prior to use, for its equilibration, and rinsed with 15 ml of 1 
M triethylammonium acetate (TEAA). This was then diluted 1:1 (containing 
approx. 10-50 OD260 units) with Milli-Q water and passed through the column 
drop wise with a syringe a total of four times. The column was then washed 
with 15 ml of 3% ammonium hydroxide solution, followed by 15 ml Milli-Q to 
remove the incomplete sequences. The column was then washed with 5 ml of 
2% trifluoroacetic acid (TFA) over a period of 1 minute to detritylate the 
product. Excess TFA was removed by washing with 10 ml Milli-Q water. Three 
1 ml volumes of 20% acetonitrile were used to elute the oligonucleotide and the 
yield determined by measuring the optical density at 260 nm. 
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Fig.3 - Confirmation of primer synthesis 
PAGE of oligonucleotide primers followed by staining with methylene blue, 
















































Table 5 - Primers for genotyping rotavirus VP7 gene 
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4 8 0 -
4 9 8 
D 5 8 3 S T 3 
( G 4 ) 
aET3 CGTTTGAAGAAGTTGCAACAG 
(+ve sense) 
6 8 9 -
7 0 9 
E 3 7 4 P ( G 3 ) 
aFT9 CTAGATGTAACTACAACTAC 
(+VC sense) 
7 5 7 -
7 7 6 
F 3 0 6 W I 6 1 
( G 9 ) 
For RT and PGR amplification to produce flill-length cDNA 
2.6.1.4 Confirmation of oligonucleotide synthesis 
To confirm the size of the oligomer, a sample was analysed on a 15% 
denaturing polyacrylamide gel with 4% cross-linking and stained with 0.2o/o 
methylene blue/aqueous solution. The appearance of a single oligonucleotide 
band of the correct size was required for confirmation. The remaining sample 
was aliquoted, dehydrated and stored at -20"C. 
2.6.2 Preparation of specimens 
For RT-PCR genotyping, dsRNA from clinical specimens containing 
rotavirus, was extracted using a modified version of the method for PAGE 
outlined in Fig. 4. The extraction procedure was necessary to remove inhibitors 
which might prevent either reverse transcription or DNA amplification 
Following the initial 'phenol-chloroform' extraction, • 
cetyltrimethylammonium bromide (CTAB) and 4 M NaCl were added 
separately to give final concentrations of 1.25% and 0.45 M, respectively. It was 
necessary to preheat all reagents and samples to 56�C prior to the addition of the 
CTAB to prevent it precipitating. The mixture was incubated at 56�C for 30 
minutes, then extracted with an equal volume of'phenol-chloroform" and then 
re-extracted with an equal volume of chloroform alone. The CTAB was used to 
remove inhibitors，such as porphyrin groups from haem, found naturally in stool 
samples丨34 and the chloroform extraction was to remove any remaining phenol. 
CTAB-NaCl extraction is particularly useful prior to the amplification of 
specimens that have been stored for long periods of time. 


































































































































































Figure 5 - Primer annealing sites on the VP7 






































































2.6.3 Reverse transcription of genomic RNA template and Polymerase 
Chain Reaction 
1 of the purified dsRNA was added to a sterile 0.5 ml microcentrifuge 
tube containing 9.8 i^l ddHzO and heat denatured at 94°C for 5 minutes, then 
cooled rapidly to prevent re-annealing. A master mix containing the reverse 
transcriptase, primers, buffer, RNAse inhibitor, BSA and dNTP was made (see 
appendix Al.5.7) and 9.2 jil added to give a final volume of 20 i^l. This was 
incubated at 37°C for one hour，resulting in the production of an RNA:cDNA 
duplex. The cDNA was then used as a template for the thermostable DNA 
dependent DNA polymerase during the amplification process. To the RT 
reaction mixture, 80 i^l of the PGR reagents required for DNA amplification 
were added (appendix Al.5.8). The PGR reaction mixture was overlaid with a 
drop of mineral oil (Sigma,USA). For the thermal cycling parameters 
(DualcycIer;Bios,USA) used to amplify the cDNA, see Fig. 6. The reaction was 
stopped by lowering the temperature to 4°C and the samples were then stored 
at4°C. 
2.6.4 PGR genotyping using full-length cDNA template 
1 \x\ of full-length cDNA amplification product (gene 7) was added to 
43.18 o f � t h e genotyping master mix (appendix A 1.5.9) containing the 
genotype-specific primers. The sample was overlaid with a drop of mineral oil 
and then subjected to the same thermal cycling parameters as for the 
production of full-length VP7 gene cDNA, except that an annealing 
temperature of 50°C was used. The reaction was stopped by lowering the 
temperature to 4°C and the specimens stored at that temperature until further 
analysis. 
2.6.5 Product identification 
9 III of PCR product was loaded onto a 1.2% agarose gel, containing 0.5 
Ilg/ml ethidium bromide in TBE buffer. Size markers, usually <l>x174, HaeIII 
(Biolabs,USA) or serotype-specific RT-PCR products from previous 
experiments were used for analysing the product size from the serotyping 
reaction (Figs. 5 and 7, Table 5). The viral genome was effective as a marker 
for the full-length cDNA product. Electrophoresis was carried out at 120 V for 
about one hour fo r the analysis of full-length cDNA products or 1.5 to 2 hours 
for the RT-PCR genotyping, after which the gels were examined under UV 
light and .photographed using Polaroid 667 black and white film (5-7 s, fll). 
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• RT-PCR genotyping products 
Lane 1 gene 9 ftill-length cDNA 
Lane 2 (|)X174, Hae III DNA size 
Lane 3 Strain HuAVa 
Lane 4 Strain Hu/Ku 
Lane 5 Strain Hu/K8 
Lane 6 Strain Hu/RV4 
Lane 7 Strain Hu/S2 
Lane 8 Strain Hu/RV5 
Lane 9 Strain Hu/Yo 
Lane 10 Strain Si/SA 11 




















Chapter 3 - RESULTS 
3.1 Epidemiology of rotavirus infections in Hong Kong 
Rotavirus was detected by Rotazyme II EIA (Abbott, USA) in 2,180 of 
10,251 stool specimens (21.3%) which were collected between July 1985 to 
April 1994 from patients with diarrhoea (Table 6’ Fig. 8) 4,925 specimens 
collected from July 1985 to Nov. 1990 had been analysed previously38. Most 
of the virus positive cases were found during winter or early spring 
(November to February) with this period accounting for 69.2% of all cases 
identified. The majority (46.2%) occurred during December and January. 
During the summer months, HRV was identified infrequently. 
All specimens of sufficient quantity (84%) were analysed by PAGE. 
Electropherotypes for specimens from 1985/90 had been examined 
previously38, but those from 1988/90 were retested during this study. The 
typical RNA migration pattern (4:2:3:2) of the eleven segments of the Group 
A RV genome was identified in 1539 of the 1825 (84.3%) EIA positive 
specimens (1731 individual cases) (Table 7). Of these, 1385 (75.9%) of the 
1825 EIA positive specimens, which represent 90% of those also found to be 
positive by PAGE possessed a long RNA pattern and 130 (8.4% of those 
electropherotype positive) possessed a short pattern. There were 24 specimens 
(23 cases) identified as mixed infections by the presence oF more than eleven 
• Annual distribution ofHRV 
HRV season Number Tested 
for HRV 
Number Positive (%) 
Jul 85 - Jun 86 571 113(19.8) 
Jul 86 - Jun 87 870 215(24.7) 
Jul 87 - Jun 88 1 Oil 186(18.4) 
Jul 88 - Jun 89 885 225 (25.4) 
Jul 89 - Jun 90 923 215(23.3) 
Jul 90 - Jun 91 1 476 314(21.3) 
Jul 91 - Jun 92 1 501 249(16.6) 
Jul 92 -Jun 93 1 800 382 (21.2) 
Jul 93 - Apr 94 1 214 281 (23.1) 
TOTAL 10 251 2 180 (21.3) 
% within parentheses 
• PAGE analysis of mEIA positive rotavirus specimens 
Electropherotype strains numbers o/o 
"Long" 165 1385 75.9 
"Short" 31 130 7.1 
"Mixed" 24 1.3 
Negative 286 15.7 
Total (Cases) 1 9 6 1 8 2 5 ( 1 7 3 1 ) 1 0 0 
7 1 
Figure 8 - Monthly distribution of 








segments. The majority, 165 of the 196 strains identified, possessed long 
electropherotypes (L) and 31 (15.8%) possessed a short pattern (S) (Table 7). 
The individual electropherotypes are shown in appendices A3.l-A3.il. Data 
on 68 long and 16 short patterns were available from the previous study38. 
15.7% of the specimens typed by PAGE were either negative or patterns too 
weak for the gene segments to be differentiated. A longitudinal overview of 
the strains during succeeding years are shown in appendices A2.1-A2.9. 
3.2 RT-PCR genotyping of rotavirus 
All specimens with RNA available from the earlier study (1985/90) and 
representative samples from 1990/94 including specimens from all 
electropherotypes, where RNA was available, were genotyped by RT-PCR. 
The VP7 gene was successfiilly reverse transcribed and the flill-length cDNA 
amplified in 493 (75.8%) of the 651 specimens tested. Ten (1.5%) specimens 
showing multiple bands following the first round amplification (Table 8). The 
genotyping method typed 82.3% (433 of 526) of specimens with a long 
electropherotype, but only 40.8% (31 of 76) of those with a short 
electropherotype. In 26.3% (20 of 76) of the specimens with short RNA 
patterns, there were multiple genotype-specific bands and 32.9% (25 of 76) 
showed no bands following RT-PCR genotyping (Table 9). There were 68.0% 
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of 651 specimens identified as having genotype 1 specificity and of these, 
91.6% (406 of 443) had a long electropherotype. All of the 25 specimens 
which were typed as having genotype 2 specificity, and in which the 
electropherotype could be determined, had a short electropherotype. These 
formed 3.8% of all specimens typed genotype 3 specificity was identified in 
2.6% of all specimens typed. In this group 23.5% (4 of 17) of the specimens 
had a short RNA pattern, and 76.5% (13 of 17) possessed a long pattern. 
There were 2.2% of the specimens with genotype 4 specificity and all these 
specimens had a long electropherotype. A further 4.8% of the specimens were 
shown to have more than one genotype-specific band: 25.8% (8 of 31) of 
these had long electropherotypes and 64.5% (20 of 31) had short 
electropherotypes, the RNA of the remaining 9.7% was too weak to visualise 
by PAGE (Table 9). 
The proportions of specimens successfully typed each year varied 
between 50% in 1987/88 to 100% for 1985/86, though for the latter only 
eleven specimens were tested (Table 10). Larger numbers of specimens were 
typed from 1988 onwards. 
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3.3 Seasonal distribution of rotavirus genotypes 
RT-PCR genotyping was used to continue the monitoring of HRV 
genotypes in Hong Kong and served as a continuation of an earlier study 
(April 1985-April 1990) in which rotavirus strains were typed using mAb 
based EIA and oligonucleotide probe hybridisation38. In five of the nine 
rotavirus seasons studied genotype 1 strains were predominant and for three 
seasons both genotypes 1 and 3 were prevalent. It was only in the 1987 to 
1988 season that genotype 3 strains were found almost exclusively, with only 
two genotype 1 and 3 G2 specimens identified (Fig. 9, appendices A2.1-
A2.9). Since then genotype 1 strains have been increasing in numbers, with 
the highest number of monthly cases found during early 1992. 
Genotype 2 strains were all found to possess a short electropherotype. 
They were identified in sporadic outbreaks involving relatively few patients in 
every season. 
For the seasons 1985/86 and 1986/87 genotype 3 strains were found in 
similar numbers to genotype 1. However, in the spring of the latter season 
genotype 3 strains were found in large numbers and this continued during the 
following season 1987/88, in which genotype 3 strains were found almost 
exclusively. The following season 1988/89, numbers of genotype 3 strains had 
decreased but were still prevalent along with genotype 1 strains. Most of the 
“RT-PCR amplification of the VP7 gene 
No. of Specimens o/o 
Positive 493 75.8 
Negative 148 22.7 
Multiple 10 1.5 
Total 651 100 
Multiple = multiple genotype specific bands 
• Genotyping of the full-length VP7 gene cDNA 
Genotype Electropherotype Total % 
"long" "short” negative 
(+vw) 
1 406 4 33 443 68.0 
2 0 23 2 25 3.8 
3 13 4 0 17 2.6 
4 14 0 0 14 2.2 
multiple 8 20 3 31 4.8 
negative 85 25 11 121 
651 
18.6 
total 526 76 49 
602 
% 82.3 40.8 71.4 100 
multiple = multiple genotype specific bands 








19.8 11 11 00 
23 16 
87- un ！ 186 18.4 .0 
un I 22 120 
89- i90 2 23.3 50 42 4.0 
90- 314 21. 78 
91 - Jun 249 16.6 35 7. 
ul 92 -Jun 93 382 21.2 0 
ul 93. 281 (23 79 
TOTAL ： 1 8 0 ( 2 1 . 3 ) 651 4 9 9 
a Rotazyme II EIA (Abbott Labs, USA) 
% within parentheses 
le present study covers the period 1990 to 1994, during which 
’ strains were only identified sporadically as single isolates, but this 
does indicate their continuing presence in Hong Kong. 
Genotype 4 strains were the least commonly identified of the four major 
human genotypes. These strains were found only during 1989 to 1992 in 
relatively small numbers. 
3.4 Comparison of RT-PCR genotyping of the VP7 gene with mEIA 
A total of 123 specimens (see Table 11) were typed by both monoclonal 
antibody based EIA (mEIA) and RT-PCR and these showed a 98.5% (65 of 
66) agreement with specimens that had been successfully typed by both 
methods. Of the 36 that had been assayed previously by mEIA, there was 
complete agreement with the current mEIA and RT-PCR typing. With this 
limited number of specimens, 81% (compared with 66% in the previous 
study38) could be typed by the mEIA. With only 90 specimens typed by 
mEIA, the specificity and sensitivity of the method could only be determined 
for specimens with genotype 1 HRV (Table 12); these were 9.1%, and 70.9%, 
respectively. 
The limit of detection by RT-PCR was obtained from the analysis of 
four standard strains (Hu/Wa genotype 1; Hu/RV5 genotype 2; Si/SAl 1 
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Figure 9 - Distribution ofHRV genotypes 






























Table 11 - Correlation of specimens typed by both RT-PCR and mEIA 
PGR 
Genotype 
Serotype (mEIA) Numbers Total 
(G) 1 2 3 
+ - + - + -
G1 + 56 10 1 67 91 
- 23 1 24 
G2 + 1 5 6 11 
- 2 3 5 
G3 + 4 4 8 21 
- 12 1 13 
Total 79 11 3 8 17 5 122 5 
i 12 - Sensitivity, specificity, and limit of detection of 
RT-PCR genotyping 
Genotype 1 Genotype 2 Genotype 3 Genotype 4 
Specificity (%) 9.1 insufficient EIA specin lens 
Sensitivity (%) 70.9 
Limit of detection (pg of VP7 gene) 
Full-length 
(pg) 
4-30 >130 530 >70 
Genotyping 
(pg) 
<2 7-120 <8 <15 
i Hu/Hochi genotype 4; and three genotype 1，two genotype 2，and 
one genotype 4 clinical isolate (Fig. 10，Table 12). An assumption that silver 
staining of dsRNA on PAGE could detect approximately 5 ng of genomic 
RNA (0.25 ng of VP7 gene -5% of HRV genome) was made. This allowed 
for the determination of the amount of dsRNA in each specimen. 15 of 
purified RNA was loaded for each of the dilution on the PAGE, whereas only 
1 |il was used for the RT-PCR therefore the amount of RNA at the same 
dilution was 1/15 for the agarose gels. i.e. ng VP7 gene dsRNA= 
5x (final dil" on agarose gel/final dil" on PAGE) /15 x (5/100) 
Where the dilution of dsRNA was insufficient to reach the end point 
dilution, the result is given as less than or equal to the amount required for a 
positive result in the final dilution. Less than 2 pg of VP7 gene is required for 
typing genotype 1-specific specimens. Genotype 2 strains are the least sensitive 
requiring between 7 and 120 pg of VP7 gene for the genotyping reaction to be 
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Table 13 - Determination of rotavirus genotype-specificity using a 
combination ofRT-PCR genotyping and electropherotyping 
Number of specimens typed Total 
Specimens 
Genotypes 1 2 3 4 
Long 406 0 13 14 433 
Short 4 23 4 0 31 
Total using 
electropherotype 
870/(78) 100/(8) 277/(7) 24/(1) 1271 
o/o of total 
(excluding 
duplicates) 
68.4 7.9 21.8 1.9 100 
• (duplicate specimens) 
Total numbers typed by RT-PCR genotyping and their 
corresponding electropherotypes 





























Specimens (Number of specimens / duplicate specimens) [strains] 
Figure 10 - Determination of the limit of detection ofHRV with RT-PCR 
genotyping 
Titration of known quantities of Hu/Hochi dsRNA by PAGE on 10% 
polyacrylamide gel. Electrophoresis was for 16 hours at 15 mA per gel, 
following which the gel was silver stained. 10 |il of full-length cDNA were 
analysed on a 1.0% agarose-ethidium bromide gel, run at lOOV for 1 hour, and 
photographed under UV light. (t)X174, Hae III DNA size marker. Genotype-
specific product was analysed under the same conditions as the first round 
flill-length cDNA product. The DNA size marker contained genotype-specific 
product from the four common human genotypes. 

e 15 - Genotype specificity of long electropherotype HRV strains 
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successful; >130 pg is thought to be required to visualise the flill-length cDNA 
as the standard strain failed to produce a visible full-length band, but was typed. 
3.5 Relationship between electropherotyping and genotyping by RT-PCR 
Of 651 specimens tested by RT-PCR, the genotype could be determined 
for 499 (76.6%) (Table 10). Of 602 specimens (Table 9) where the 
electropherotype could be determined 77.1% (82.3% and 35.5% of all 
specimens with long and with short electropherotypes, respectively), were typed 
by the RT-PCR method alone. It has been shown in this study and others that a 
given strain always has a constant electropherotype and g e n o t y p e i7’38’53’56，85，188， 
with the exception two specimens with a single electropherotype but different 
serotypes丨丨.This suggests it should be possible to combine the results from the 
two methods to enable typing of a larger proportion of the strains. Of the 1515 
(1416/99) specimens containing a single HRV strain, 1365 (1271/94)(90.1%), 
and 142 of the 196 (72.4%) different strains could be typed using a combination 
of electropherotyping and RT-PCR genotyping (Tables 13 and 14). Of those 
with ^ long RNA pattern, 1257 of 1385 specimens (90.8%) were typed, as were 
108 of 130 specimens (83.1%) with a short pattern. Of the 142 strains typed, 
75.8% (125 of 165) of long electropherotype strains and 54.8% (17 of 31) with 
a short pattern had their genotype specificity determined. For 92 specimens. 
including 22 strains with a long RNA pattern and eight strains with a short 
pattern, there was no material available for typing. The remaining 38.7% of the 
150 specimens (3.8% of the total) not typed, were negative for RT-PCR, this 
included eighteen long electropherotype strains and six short electropherotype 
strains. 
Using a combination of electropherotype and RT-PCR genotyping, the 
genotype for 1365 (1271/94) of all 1423 (1326/97) (95.9%) specimens, which 
were electropherotype positive and available for genotyping, could be typed. 
Following the removal of duplicate specimens 89.8% of 1416 cases were 
typed. Of these 68.4%, 21.8%, and 1.9% were shown to possess genotypes 1, 
3, and 4-specificity. There were 7.9% which had genotype 2-specificity and a 
short electropherotype (Table 13). Tables 15 and 16 show the designation of 
genotype to long and short electropherotypes, respectively. 
3.6 Atypical rotavirus strains 
Unusual HRV specimens were identified in ten cases during the analysis 
of the 1539 electropherotype positive specimens. Two specimens from a strain 
with a short electropherotype had genotype 1-specificity (SO 17), with two 
other specimens with the same short electropherotype exhibiting multiple 
genotype (G1 and G2) specificity, no specimens from that electropherotype 
( s o 17) were shown to have only the expected G2-specificity. Two single 
isolates (S022, S029) were shown to have G1-specificity by RT-PCR. 
Another strain (S003) was shown to have the same type-specificity by both 
RT-PCR and mEIA. Another short electropherotype strain had two 
representatives, one typed by RT-PCR the other by mEIA showing genotype 3 
and 2 specificity, respectively. Two short strains (S024 and S027) were also 
typed as possessing genotype 3-specificity. The electropherotype of a single 
isolate (SO 10) revealed a super- short RNA pattern and was typed by mEIA^^ 
and RT-PCR as genotype 3. Two strains (L024 and LOS8) with a long RNA 
pattern had been identified as having subgroup I specificity^^ and shown to 
have genotype 3-specificity by RT-PCR genotyping. 
3.7 Specimens exhibiting multiple genotype specificities 
Thirty one (4.8%) of the 651 specimens typed showed more than one 
genotype specific band when analysed on the agarose gels (Table 17). Six 
(19.3%) had Gl, G2, G3, and G4-type specific bands; 6.5% each were shown 
to have genotypes I and G3 or Gl and G4-specificities and to possess a long 
electropherotype. The largest group of specimens (67.7%) with multiple type 
specificities, had both genotype 1 and 2-specificity and the electropherotype 
where it could be determined in 18 (85.7%) specimens was short. Although, 
-Analysis of multiple genotype specimens 
Genotype Electropherotype Total o/o 
"long" "short" negative 
(+vw) 
1 + 2 0 18 3 21 67.7 
1 + 3 2 0 0 2 6.5 
1 + 4 2 0 0 2 6.5 
Multiple' 4 2 0 6 19.3 
Total 8 20 3 31 
o/o 25.8 64.5 9.7 100 
‘Specimens containing >2 genotype-specific bands 
genotype 1 strains were prevalent at the time these specimens were identified 
PAGE analysis did not identify any mixed infection in these specimens. The 
strains with short RNA patterns, where the electropherotype could be 
determined, constituted 71.4% of all the specimens with multiple genotype 
specificities. 
3.8 HRV RT-PCR genotyping primers 
The primers proposed by Gouvea et al'®^ for genotyping HRV were 
analysed in three ways. 
Firstly, all strains for which the VP7 gene nucleotide sequences were 
available were analysed for sequence differences in each of the six variable 
regions (VR-A to VR-F) as well as in the 5' and 3' non-coding regions, using 
the primer sequences as the reference points (see fig. 5, appendices A4.1-
A4.8). For strains where more than one sequence has been submitted to 
Genbank NIH, USA database, a single sequence was used in the analysis 
unless nucleotide substitutions were present. Strains belonging to genotypes 
G1 i6 G14, except the avian G7, were included in the analysis (A4.9). The 
largest group of specimens (67.7%) with multiple type specificities, had both 
genotype 1 and G2-specificity and the electropherotype where it could be 
determined in 18 (85.7%) specimens was short. Although, genotype 1 strains 













END9 - END9 -5.3 
BEG9-END9 -8.5 64.2 50.9 32.7 1059 
G1 -G1 -8.1 
G1 -END9 -8.4 59.8 49.8 33.0 746 
G2-G2 -5.3 
G2 - END9 -6.5 61.9 50.3 33.1 652 
G3-G3 -13.3* 
G3 - END9 -5.1 374 
G4-G4 -3.6 
G4-END9 -4.8 59.4 50.2 34.0 583 
10 stable hairpin structures 
:>9KCal/mol is considered stable 
were prevalent at the time these specimens were identified PAGE analysis did 
not identify any mixed infection in these specimens. The strains with short 
RNA patterns, where the electropherotype could be determined, constituted 
71.4% of all the specimens with multiple genotype specificities. 
Secondly, a search was conducted using DNASIS with the Genbank, 
NIH, USA database using the primer to identify sequences within the database 
which possess a high degree of nucleotide homology. This would enable the 
identification of potential sources of incorrect annealing sites and to confirm 
the specificity of the primers for a given genotype. 
Thirdly, the primer sequences were analysed for secondary structure, 
stability, melting temperature and optimal annealing temperature using the 
Macintosh-based 01igo4 primer analysis package. The results of the analysis 
are shown in Table 18. 
Discussion 
The present study was designed as a continuation of the work initiated as 
part of Raymond Chan's PhD thesis 'Epidemiology and genetic variation of 
human rotavirus infections in Hong Kong'^^ The following is an abstract 
from his thesis: 
The epidemiology of human rotavirus infection in Hong Kong was studied 
between July 1985 and November 1990. Rotaviruses were detected in 1046 (21.2%) 
of 4925 children, of which 89 (8.4%) were hospital-acquired. Rotavirus infections 
showed a typical seasonal pattern which peaked during winter. 
The rotavirus subgroup of 807 strains was determined by monoclonal-based 
ELISA which showed 56 (7%) were subgroup I and 738 (93%) were subgroup II. 
Serotyping of 367 specimens with a monoclonal-based ELISA showed 181 (49.3%) 
^ere serotype 1, 17 (4.6%) serotype 2, 158 (43.1) serotype 3. and 11 (3.0) serotype 
4. In addition, 470 of these 558 strains were serotyped by a dot hybridisation assay 
using four oligonucleotide probes constructed from the nucleotide sequences of VP 7 
of human serotypes 1, 2, 3, and 4. 271 (58%) were successfully serotyped into 217 
serotype 1, 26 serotype 2, 12 serotype 12, and 16 serotype 4. Complete agreement 
way achieved in 189 specimens which were typahle by both ELISA and dot 
hybridisation methods. 
The genetic diversity of the rotavirus strains was also studied hy 
polyticrylcimide gel electrophoresis (PAGE). A total of 6H different lon^ ‘ and 16 
different 'short ‘ electropherotypes were identified. Different rotavirus serotypes with 
identical electropherotypes were not detected. Heterogeneity of electropherotypes 
within a serotype was observed in strains of all the four serotypes. 
The result of this study clearly indicated that human rotavirus strains showed 
extensive genetic variations, with one or two major electropherotypes predominant 
in each year at the peak of the epidemic. The oligonucleotide probe hybridisation 
assay has been proved to be useful as an alternative method for sero typing of human 
rotavirus in stool specimens. Serotype 1 strains were most frequently identified 
followed by serotype 3. The predominant serotype (s) may vary from year to year. 
Several problems were encountered in the previous study, both with the 
monoclonal based EIA and with the oligonucleotide probe assay. For the 
mEIA the problems, which have also been identified in other studies include 
the limited availability of type-specific monoclonal antibodies^^^ and the 
potential inability to serotype rotaviruses which have minor changes in the 
amino acid sequence in the outer protein VP7 epitope at or near their binding 
Site53’i45,165,254. ^^  additioii, mEIA serotyping was unable to type specimens for 
which inadequate amounts of the outer capsid proteins VP7 and VP4 were 
available in the original specimen or possibly due to the loss of the capsid 
during storage (32.4% lacked the outer capsid in the previous study^^). 
The oligonucleotide probe assay offers a different approach as it is 
directed against the viral genome and divides HRV into genotypes. One of the 
major concerns with this approach is the safety aspect dealing with the 
handling and disposal of high energy P-emitting Phosphorous-32 labelled 
oligonucleotide probes. In addition to this, the genotype 3-specific probe in 
the previous study was only able to recognise 7% of the genotype 3 strains^s. 
Genotype 3 is probably the most diverse*35"i’76’77 j^ . jg possible that the failure 
of the genotype 3-specific oligonucleotide probe was due to natural mutations 
in the VR-B of the VP7 gene, against which the probe was directed. 
The previous study indicated that extensive genetic variations exists in 
the rotavirus population in Hong Kong. There were 84 different strains and all 
four of the common human serotypes were identified^s. The continuous 
monitoring of rotavirus strain and serotype changes in the present study 
provides a better understanding of the natural succession of rotavirus 
genotypes, which is vital for the development of an effective vaccine. In 
addition, new and emerging strains can be identified. In order to enhance 
sensitivity and specificity in typing rotavirus, an alternative method was used 
that was based on the RT-PCR genotyping method reported by Gouvea et 
flr/i()6..This can avoid the drawbacks of both mEIA and oligonucleotide probe 
hybridisation assays. 
4.1 Epidemiology of HRV in Hong Kong 
Out of the 1767 rotavirus infections identified with clinical data, 82.8% 
were found in infants of less than eighteen months, with the majority of those 
younger than twelve months (64.6%)，which is similar to that observed in 
other studies24’58，i35. 
Annually, 16.6-25.4% of stool specimens were found to be positive for 
rotavirus by Rotazyme II EIA (Abbott, USA), with a mean of 21.3% of the 
10,251 stool specimens over a 10 year period. The majority of cases (69.2%) 
occurred during winter or early spring with the largest number of cases during 
December and January (46.2%) (Table 6, Fig. 8). Peak activities of HRV 
infection occurring in the cooler months of the year have also been observed 
in most non-tropical locations '^^ '^ '^''^ ^ and certain tropical locations^^''^'. 
There is a high degree of variability in RNA electropherotypes identified 
between different strains by PAGE. However, electropherotyping by PAGE 
does not have any direct relationship to serological classification^'. With the 
exception of two strains with identical RNA pattern but different genotype", a 
single electropherotype generally corresponds to a single sub-type or 
genotype38，53，56，i88 ^^ shown in this study. In this study each distinct 
electropherotype was considered to be an individual HRV strain. 
The majority of the 196 strains (165 strains and 1385 oF 1539 (90.0%) 
of electropherotype positive specimens) possessed a long RNA pattern (Table 
7, Appendix A3). The predominance of strains with long electropherotypes 
has been identified in other settings'^ '^^ ^^ There were 31 (9%) strains, with 
short RNA patterns. As in other localities^ '^^ ^^ these short electropherotypes 
were identified sporadically in small numbers in every season. Co-infection 
with two long electropherotype strains were found in twenty of 24 specimens 
with mixed infection and four specimens had both long and short 
electropherotype strains. The Rotazyme II EIA is more sensitive than PAGE 
for identifying group A HRV infections as 15.7% of all specimens that were 
EIA positive were negative or too weak to type by PAGE. 
The distribution of rotavirus electropherotypes showed that the virus 
population in Hong Kong has high genetic variability and is dynamic. It has 
been shown even single nucleotide changes may give rise to distinct 
electropherotypes^^ whereas other new strains may arise from the 
accumulation of mutations. Changes in the nucleotide sequence and secondary 
structure rather than nucleotide numbers, result in changes in the migration 
pattern of the segments?�. From analysis of electropherotypes using higher 
concentration of acrylamide in PAGE (12.5%) it is possible to show that a 
strain actually contains a population of sub-strains with gene segments which 
migrate slightly differently from the parent strain?]�. At lower resolution 
achieved with 10% PAGE these would not be resolved. 
4.2 RT-PCR genotyping of rotavirus 
Differences in antigenicity of the outer capsid proteins VP7 and VP4, 
have been used to divide rotavirus into several distinct serotypes. Sequence 
analyses of the VP7 gene have identified serotype-specific sequences. 
Classification of rotavirus into these serotypes by analysis of the genome of 
the outer capsid protein VP7 is termed genotyping. Based on this relationship, 
serotyping and genotyping are considered similar forms of classification of 
these rotaviruses. While serotyping refers to the detection of serotype-specific 
epitopes by specific immunoglobulins, genotyping refers to the detection of 
the serotype-specific ribonucleotide sequences of the VP7 gene. 
In order to overcome technical problems associated with monoclonal-
based EIA (mEIA) serotyping and to enhance the sensitivity of rotavirus 
typing，a RT-PCR method for rotavirus genotyping was introduced. RT-PCR 
genotyping consists of two stages. The first stage involves conversion of VP7 
the gene RNA into cDNA and the amplification of the full-length cDNA 
product (Figs. 6 and 7). The second stage utilises the genotype-specific 
primers with the full-length cDNA template for a second round of PGR. 
Following amplification, the size of the product can be determined and hcncc 
the genotype-specificity of the strain can be identified (Fig. 7). 
In the present study the full-length cDNA copy of the VP7 gene could be 
visualised in 493 of 651 samples (75.8%) following reverse transcription and 
first round PGR amplification (Table 8). Of all specimens positive by the EIA 
Rotazyme II (Abbott Labs., USA), 76.6% (499 of 651 specimens) could be 
typed with RT-PCR (Table 9). This compares favourably with mEIA, which 
was only capable of typing 66% of Rotazyme II positive specimens. 96% of 
specimens which were not typable with the mEIA method were shown to lack 
an outer capsid^^ A comparison between RT-PCR and mEIA shows 98.4% 
(60 of 66) agreement with specimens positively typed by both methods 
confirming RT-PCR can accurately type rotavirus (Table 11). 
4.2.1 Modifications to methodology 
In this study only G1 to G4 strains were targeted for identification by 
RT-PCR. These G-types also accounted for 97% of all specimens shown to 
contain virus with the outer capsid protein VP7 in the past study38. Therefore, 
in the current protocol the HRV strains were tested initially for G1-G4 
specificity. In our two step RT-PCR protocol, if a full-length cDNA positive 
specimen did not display G1-G4 specificity then it would be assessed for G8 
and G9-spccificity. This would prevent wastage of G8 and GQ-spccific 
primers as well as simplifying the experimental procedure and analysis of the 
results. 
The primers used in the RT-PCR were derived from the protocol 
reported by Gouveaio6. The methodology was also followed initially but it 
was found to lack sensitivity，producing only weak bands of full-length 
cDNA，even with the positive controls. The methodology was therefore 
modified. The modifications included the introduction of an initial 
purification step to remove the inhibitors of reverse transcriptase and Taq 
polymerase, a change in the reverse transcriptase used, and the division of the 
single RT-PCR into two optimised stages. 
For efficient amplification it is necessary to remove inhibitors which 
may interfere with the reverse transcriptase and Taq polymerase, from the 
processed specimens prior to These inhibitors include porphyrins 
from haem, found within bile, which inhibit both reverse transcriptase and 
Taq polymerase activity. The purification of stool specimens was modified by 
the use of the cationic detergent hexadecyl trimethyl ammonium bromide 
(CTAB) in the extraction to remove non-specific inhibitors (Fig. 4). This 
method was originally used in the purification of the Norwalk agent from 
stooli34 and had not previously been used for RT-PCR of HRV. CTAB is able 
to precipitate the inhibitors by forming an insoluble complex which is 
removed by "phenol-chloroform" extraction. This modification increased the 
number of specimens which could be typed by the RT-PCR method. It was 
particularly useful with specimens that had been stored for a long period of 
time, in which the sensitivity of the method was lower. 
The first step of reverse-transcription, using the genomic VP7 dsRNA as 
template to produce full-length cDNA，was considered the rate limiting step 
since the efficiency of RT can be as low as The initial use of the Taq 
polymerase buffer which was not optimised for the reverse transcription in 
Gouvea's m e t h o d w a s an important factor for the lower sensitivity in 
detection. The RT-PCR first round amplification was therefore divided into 
two steps allowing the use of optimised buffers for the reverse transcription 
step and the PGR step. Moloney murine leukaemia virus reverse transcriptase 
(MoMLV) was used in the study as it lacks RNaseH activity^^'. This reduced 
the risk of degradation of the RNA template and improved the chance of 
obtaining a full-length transcript. The disadvantage of the RT enzyme over 
that of avian myeloblastosis virus RT is the lower optimal temperature ( 3 7 � � 
compared with 42°C). Using a lower temperature during the RT step may 
allow the formation of secondary structure within the target gene which may 
prevent the synthesis of a full-length cDNA transcript. The modified two 
stage protocol greatly improved the sensitivity as exemplified by the greater 
than 30 fold decrease in the amount of template required to type the strain 
Si/SAll (see Table 12, Fig. 10). 
Other modifications included the omission of the 7% dimethyl 
sulphoxide (DMSO) from the reaction mixture. This did not appear to affect 
the assay's sensitivity. The concentration of Mg2+ ion had already been 
optimised in the buffer provided by the manufacturer (Amersham) and was 
not re-adjusted. 
4.2.2 Rotavirus genotypes 
The RT-PCR method was able to type 433 (82.3%) of the long 
electropherotype specimens (Table 9). However, it was not as effective with 
the short electropherotypes, only being able to genotype 31 (40.8%) with a 
further 20 (26.3%) showing multiple genotype-specific bands and 25 (32.9%) 
negative for RT-PCR genotyping. A similar difficulty was also apparent for 
genotype 3 (G3) strains, with 64.6% of strains not typed. A comparison of 
known sequences for genotype 2 and genotype 3 strains (Appendices A4.1 to 
A4.8) to which the primers bind (5丨,3’ non-coding regions, VR-C (VR-6), and 
VR-E (VR-8)) indicated there is a high degree of homology with the 
primers丨3丨’丨78，212’ therefore it is unlikely that the primers are not specific. A 
single strain, LOOS (Table 15), accounted for 55% of the specimens in which 
RT-PCR failed to confirm the presence of genotype 3 HRV. Failure of the 
PCR might arise from the presence of inhibitors, but it seems unlikely that this 
would affect one genotype or strain selectively. In the earlier study, 
oligonucleotide probe hybridisation had typed only 7% of such specimens, 
although most of these strains were shown to have G3-specificity by mEIA^^. 
Possibly the VP7 gene of L005 has an unusual nucleotide sequence, or 
mutation at primer annealing sites，or a secondary structure which interferes 
with the reaction. Nucleotide sequencing would be necessary to further study 
the nature of the problem. 
Epitope conformation has been shown to be important for antigenicity in 
many v i r u s e s i n c l u d i n g HRV75’228. Variation within the type-specific 
neutralising epitopes of the VP7 protein have been demonstrated by mEIA". 
Variation was evident when a specific mAb was unable to recognise the 
variant epitope, and typing was then only possible if an additional mAb was 
available. Such variants have been identified in both G1 and G4 strains 53，264 
The RT-PCR appears less sensitive than mEIA to minor changes in the 
epitopes, but the primer binding sites must be maintained. It is possible that 
some of the electropherotype positive specimens which could not be typed by 
RT-PCR were sub-types, possessing distinct minor variations in the genome 
within individual genotypes", which were not rccognised because of 
mutations at sites critical for successful genotyping'^^ This is one 
disadvantage of the use of PGR primers directed against the variable regions. 
Other studies have also shown difficulties in amplifying G2 strains 
The sensitivity was improved by replacing the common primer END9 with a 
anti-sense primer RV1248 which binds in the region between VR-D and VR-
E to nucleotides 650 to This would not be suitable for general use, 
because G3 (VR-E) and G9-specific (VR-F) products could not be amplified. 
However, this does suggest that the difficulty in typing may be due to 
secondary structure within the gene, preventing the reverse transcriptase 
synthesising the complete transcript. The problem of secondary structure may 
be overcome by the replacement of the MoMLV RT with avian 
myeloblastosis virus RT and raising the temperature to 42°C. An alternative 
enzyme is the rTth DNA polymerase (Perkin Elmer Cetus, USA) which in the 
presence of MnCl! at 72�C can efficiently reverse transcribe RNA and can 
then be used for PGR in the same reaction. The high temperature should 
remove any secondary structure. The above study also had difficulties in 
typing G4 strainsi92. However, in this study all specimens with serotype 4-
specificity in the mEIA produced both full-length cDNA and a G4-specific 
product. 
Multiple bands were found on the gel in 31 (4.8%) of specimens 
following genotyping (Tables 9 and 17). The problem of non-specific 
amplification was resolved in most cases by using 1/10 or 1/100 dilutions of 
the full-length cDNA as template for the genotyping. The number of 
specimens negative for genotyping was 4% less than that observed following 
the production of full-length cDNA. Thus, a specimen from the first stage 
may appear to be negative because there is insufficient cDNA to be visualised. 
Several Rotazyme II EIA positive, electropherotype negative specimens 
from patients with diarrhoea were typed with RT-PCR suggesting that the 
PCR is more sensitive than PAGE of viral RNA as a detection method. It was 
also found that 18.3% of RT-PCR negative specimens were positive with 
PAGE electropherotyping. This indicates that for these specimens the 
sensitivity of the RT-PCR had been reduced for reasons as described above. 
Table 10 shows that there are great differences in the ability of RT-PCR 
to type strains from year to year (50-100%). This appears to be dependent on 
the prevalence of G2 and G3 strains e.g. from July 1987 to July 1989，only 
124 (57.3%) specimens were typed due to the high numbers of G3 strains. In 
those seasons (e.g. July 1989 to July 1991) with few G3 and short 
electropherotype (G2) strains, 86.7% of specimens were typed. In 1992，71% 
of strains could be typed but a large proportion of those not typed (40%) were 
short RNA patterned strains producing both Gl and G2-specific amplification 
products (Table 17). This indicates that RT-PCR is still not the fool-proof 
method for genotyping. Therefore a combination of mEIA and RT-PCR 
maybe a better approach to achieve a higher proportion of strains being typed 
for epidemiological studies. 
4.3 Comparison of RT-PCR genotyping with EIA typing 
Only for G1 strains were there sufficient samples available to determine 
the sensitivity (70.9%) and specificity (9.1%) of the RT-PCR method against 
the mEIA (Table 12). The lower specificity is to be expected when mEIA is 
used as the "gold standard" because the RT-PCR method can type rotavirus 
that lack the outer capsid, which cannot be typed by mEIA. Studies have 
shown that 25-35% of HRV positive specimens cannot be typed due to the 
loss of the outer capsid proteins during storage^^''^^'^". RT-PCR thus 
increases the number of potentially typable specimens and gives a more 
accurate view of the HRV genotypes causing symptomatic infection in the 
environment. 
•The amounts of template (VP7 gene) RNA required to produce a visible 
full-length cDNA and type-specific product by agarose gel electrophoresis are 
shown in Table 12. All four genotypes require pg levels of template dsRNA 
for successful typing reactions. G2 strains were the least sensitive, requiring 
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more than 130 pg of VP7 gene for the full-length cDNA to become detectable. 
This again reflects the problems associated with typing G2 strains. A much 
larger amount of genomic RNA is required for genotype 2 strains than for 
other genotypes, indicating RT-PCR is less efficient for typing G2 strains. The 
replacement of the antisense common primer END9 with the primer RV1248, 
as described above has been proposed to rectify this problem^ '^^ . 
Gouveai�6 found that the RT-PCR genotyping method required 2 ng of 
genomic RNA or 100 pg of the VP7 gene, the equivalent of 10^  particles, a 
sensitivity similar to that for G2 strains. This is at least twelve times less 
sensitive than our modified methodology when applied to the genotype 3 
strain Si/SAll (Table 12), because the end point dilution for a positive RT-
PCR in serially diluted RNA samples was not determined in the present study. 
For G1 strains compared to the G3 strain Si/SAl 1 in Gouvea's report�6，there 
was a greater than 50 fold increase in sensitivity (Table 12). This 
improvement was achieved by changes in the protocol for purification of the 
RNA from stool specimens, and by the division of RT and PGR into the two 
component stages (Fig. 6). Inhibitors of both RT and PGR are thought to be 
present in 50% of specimens^^^ The introduction of the purification method 
for the genomic RNA'^^ using cetyl trimethylammonium bromide 
precipitation and other minor additional adjustments, (Fig. 4) was thought to 
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improve the sensitivity by the removal of those inhibitors. It has been shown 
in other studies that the removal of inhibitors greatly improved the sensitivity, 
with limits of detection as low as 6 x lO'^  particles/ml'^^ In addition the 
separation of the RT and PGR for the production of flill-length transcripts 
enhanced the sensitivity of detection. By optimising these steps, particularly 
the RT, it was shown clearly that the two stage method reaction was more 
efficient: previously negative clinical samples produced visible bands on gel 
electrophoresis and previously weak positive controls produced strong bands. 
The only drawbacks to this modification were the slight increase in processing 
time and an increased risk of contamination, though the latter was not in fact 
encountered as shown by the appropriate controls. 
4.4 Relationship between Electropherotyping and RT-PCR genotyping 
A total of 464 of the 602 electropherotype positive specimens (77.1%) 
could be typed by the RT-PCR method alone (Table 9). This comprised 
82.3% (433 of 526) of all long electropherotypes and 40.8% (31 of 76) of all 
short electropherotypes. The association of an individual electropherotype (i.e. 
strain) with a single genotype specificity was established in this study. This 
has also been confirmed in other reportsi7’53’56’85，i88 The only reported 
exception being two strains which had identical electropherotype but diFferent 
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genotype''. However, it is possible this arose from a lack of resolution with 
the older PAGE techniques^l 
All specimens positive for rotavirus by Rotazyme II were analysed by 
PAGE and their electropherotypes determined. Therefore, using the 
hypothesis that an individual strain will consistently show the same 
electropherotype and genotype, it may be possible to determine the genotype 
of many specimens by genotyping representatives of each electropherotype 
and hence conferring the genotype to the remainder of those with an identical 
electropherotype56，i88. The combination of RT-PCR genotyping and 
electropherotyping greatly improves the ability to type strains. A combination 
of both methods achieved the typing of 90.1% of all the specimens in this 
study that contained only single HRV strains (Tables 13 and 14). 870 (68.4%) 
of the 1271 cases were shown to have G1-specificity, indicating that it is 
clearly the predominant type; 100 (7.9%) specimens had G2-specificity and 
all those possessed a short electropherotype. G3-specific strains were 
identified in 277 (21.8%) of specimens and 24 (1.9%) were G4, which was the 
least common genotype found during the period of the study (Table 13). Of all 
the individual cases with long and short electropherotype, 90.5% (1171 of 
1294) and 82.0% (100 of 122)，respectively could be typed by this means. 
1423 (1326/97) of 1515 (1416/99) of specimens were available for both 
electropherotyping and RT-PCR genotyping (Table 14). Typing was achieved 
in 95.9% of these 1326 individual cases. The remaining 9.9% of specimens 
which could not be typed may have failed for reasons as described above. 
This study has shown that in Hong Kong the majority of strains possess 
genotypes G1 to G4 however, the appearance of new genotypes in these 
specimens cannot be excluded. 
Using the combination of methods three times more specimens were 
typed and in the case of G3 strains 17 times more were typed (Table 13). This 
approach to typing a few specimens and designating genotype specificity to 
the remaining members with the same electropherotype, although still 
hypothetical, may increase the overall number of electropherotype positive 
specimens which can be typed (from 77.1% (464 of 602) to 90.1% (1365 of 
1515)) and also reduces the number of specimens needing to be typed, saving 
both time and cost. 
4.5 Rotavirus genotype distribution in Hong Kong 
In the present study genotype 1 was the predominant type in five of the 
nine HRV seasons. Both G1 and G3 were prevalent for three of the nine years. 
It was only in the 1987-88 season that G3 strains were found almost 
exclusively, with only two G1 strains being identified (Fig. 9). From the 
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analysis of 28 previously published studies, most of which were hospital-
based, but some were community-based, 74% of 5,419 strains could be 
typed277. The summary showed G1 was the most prevalent, accounting for 
61% of those typed. It was shown to be the predominant type in 19 of the 28 
studies from North America, Africa, Australia, and Europe???. The prevalence 
of strains with G1-specificity is also important, as they are generally 
associated with more severe diarrhoea^^^ 
All G2 strains in this study were shown to have short electropherotypes 
and were found in all seasons studied. A study summarising reports from 
Medline identified G2, in numbers similar to those of G3 and G4 strains, but 
occasionally becoming p r e d o m i n a n t � ” . As in most reports from around the 
world, G2 strains in Hong Kong, appeared to cause sporadic outbreaks 
involving relatively few patients (Table 16 and Fig. 9). 
In 1985 G3 strains were found in similar numbers to G1 strains, but in 
the following two seasons their numbers increased, peaking in the 1987-88 
season. During the 1988-89 season the number of G3 strains diminished, and 
this genotype was not identified during the following season. Following the 
1989-90 season G3 strains were only identified sporadically as single isolates 
(Table 15, Fig. 9). This indicates their continuing presence in Hong Kong. 
The majority of G3 strains were shown to possess a long electropherotype. 
This was 76.5% of those specimens individually genotyped and 99% of 
specimens typed using a combination of genotyping and electropherotyping. 
There were three strains (1%) with a short electropherotype which is usually 
associated with G2 strains. 
During the whole period studied, G4 strains were identified in only 24 of 
the 1731 cases (1.4%). The prevalence or scarcity of particular HRV 
genotypes remains unexplained. In four severe epidemics over a 16 year 
period in Australia, the VP4 neutralisation epitopes of G4 isolates retained a 
high degree of sequence homology. This suggests that the periodicity of HRV 
is not necessarily a result from changes within the neutralising epitopes of 
either capsid protein^®^ Natural infection confers type-spedfic immunity, but 
the supply of susceptible individuals in the first year of life is continually 
replenished. Given enough susceptible children, a single genotype might 
remain predominant over a long period of time. This appears to have been the 
case in Hong Kong from 1985-89 with G3 and from 1989-94 with G1 strains. 
Second or subsequent infections with different genotypes results in less severe 
illness because heterotypic antibodies provide some degree of protec t ion . 
Overall, the data from this study show G1 strains to have been the 
predominant type in Hong Kong in the majority of seasons, as has been 
reported from most locations worldwide^^^ Clearly, any successful vaccine 
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must confer protection against G1 strains. However, the data also showed that 
the epidemiology of rotavirus in Hong Kong is a dynamic one with the 
prevalence of the different genotypes varying over time. It is still not possible 
to predict which strain or genotype will be predominant in subsequent HRV 
seasons. This was also shown in other reports^ '^^ ^ '^^ ^^ G1 strains may or may 
not continue in overall predominance: G4 strains replaced G1 to some extent 
in the latter part of 1990. The presence of several types in one season and the 
great variation over time show that a monovalent vaccine against G1 would 
give inadequate protection. 
Sequences important in defining protein conformation, for example, the 
type-specific variable regions of the VP7 gene, are all well conserved for each 
type but not between types. It has been suggested that their conservation is 
due to the fact that they collectively define type-specificity by determining the 
conformational structure of the protein丨45’ 丨46，丨 65 A mutation arising in one of 
these regions which results in a change of amino acid, may be silent, or the 
protein conformation may change slightly resulting in an altered antibody 
binding profile. If the mutation takes place in VR-B (5), VR-D (7), or VR-E 
(8) this may give rise to neutralisation escape mutants'^^l Genetic drift will 
occur within genotypes, but the differences between the variable regions of 
the relevant genes in the different genotypes are such as to make a shift of 
genotype highly unlikely. The genetic variability within HRV is a result of 
several factors. The transcription fidelity of the transcriptase is low and allows 
a high mutation rate particularly in ssRNA viruses, but HRV is thought to 
possess some proof-reading capability50’88 
It is only when a mutation confers some advantage that selective 
pressures will enable the mutant to emerge as a new strain. Once the strain has 
emerged, it is necessary for it to be able to survive and spread within the 
community. Many individual strains were seen once only during the study. 
This may indicate low infectivity, low pathogenicity or limited ability to 
survive in the inanimate environment. A strain well adapted both to the host 
and to the external environment will be found in large numbers over several 
seasons, as the strain LOOS was (Appendix A3.2). 
4.6 Specimens containing atypical rotavirus strains 
In human rotaviruses it has been generally accepted that all short 
electropherotype strains have a subgroup I antigenicity and serotype 2 (G2) 
specificity, while long electropherotype strains have subgroup II antigenicity 
with either serotype 1 (Gl), 3 (G3), or 4 (G4) specificity^^'^^''^^ Atypical 
HRV strains are defined as isolates which do not fit this relationship such as 
short electropherotype strains with Gl, G3, or G4-specificity or long 
electropherotype strains with G2-specificity. Ten atypical HRV specimens 
were identified in this study as described above (3.6) (Tables 15 and 16). 
While the atypical two specimens of SO 17 short electropherotype were 
typed as Gl, there were three others of the same electropherotype which 
possessed both Gl and G2 specificities. The reason for the absence of G2 and 
the presence of Gl-specific PGR products in the sample remains unknown. It 
may be as a result of sporadic contamination or more likely contamination of 
the stool or genomic RNA prior to typing. Two Gl specimens (S022, S029) 
were found to possess a short RNA pattern and Gl-specificity, S003 was also 
shown to have a short electropherotype with type 1-specificity by both RT-
PCR and mEIA^^ One specimen (S007) had been genotyped as G3 but 
another specimen with the same electropherotype was G2 by mEIA. S024 and 
S027 were single isolates with short electropherotypes and were shown to 
possess G3-specificity with RT-PCR. 
The electropherotype SO 10 was shown to possess a super-short RNA 
pattern, where gene segment 10 migrates much more slowly than usual, and 
was typed by both RT-PCR and mEIA as Other super-short strains 
have also been reported and were classified with G8-serotype specificit/，〗。^ 
The G3-specific primer for the RT-PCR is directed against the VR-E. It is 
possible that the mAb 5E8 (the mAb used in this study for serotype 3) is 
directed against the VP7 epitope encoded by this region. As this 
of the gene in G3 and G8 strains which share a high degree of homology, this 
might explain cross-reactions between the two types for both RT-PCR and 
mEIA. Such cross-reactions between G3 and G8 mAbs have been reported 
previously with VR-E of G3 and G8 s t ra ins 丨。丨’⑷.These results indicate that 
the VR-E region should not be used to differentiate these genotypes. 
The electropherotypes L024 and L038 both possess long RNA patterns, 
and have subgroup I specificity^^ These strains were shown to have G3 
specificity by RT-PCR in the present study. Other reports had also identified 
similar HRV strains^^ Since most animal rotavirus strains possess long RNA 
patterns and subgroup I antigenicity these strains are thought to be of animal 
origin. Animal rotaviruses with long electropherotypes and G3 serotype such 
as Si/SAll have been well studied. Rotavirus isolates, L024 and LOS 8 from 
the present study may have arisen from animal source. This observation raised 
an important question on the possibilities of human diarrhoeal diseases caused 
by rotavirus of animal origin. This is exemplified by the wide spread outbreak 
of .water-associated adult diarrhoea rotavirus (ADRV) in China'^^. This 
ADRV was classified as group B rotavirus (which do not cross-react with 
group A rotavirus) and was originally proposed to have been of animal 
. . 1 2 9 
origin . 
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4.7 Stool specimens with multiple rotavirus genotypes identified by 
RT-PCR 
A total of 31 out of 651 specimens (4.8%) exhibited more than one 
genotype-specific band following RT-PCR (Tables 9 and 17). Of particular 
interest were the eighteen specimens with short electropherotype which 
exhibited G1 and G2-specific products. It is likely that these short 
electropherotypes were of G2-specificity for the reasons discussed 
above72，77’i35 The difficulty arises in explaining the presence of the Gl-
specific PGR product. From analysis of the cDNA sequence data for the VP7 
gene of G2 rotavirus strains, only 50% homology exists in the VR-B64,i09，n4 
(the region the G1 primer was designed to bind). With the high level of 
specificity in RT-PCR methods it is unlikely that G1-specific primer would 
anneal to a G2 strain VR-B and PGR take place. There are several possibilities 
which may account for this. 
Firstly，the specimen may contain two different strains of HRV with 
different G specificities and concentrations. From patients from whom more 
than one specimen was collected, it is established that RT-PCR is capable of 
correctly typing those specimens which were negative for electropherotyping. 
Therefore, in a mixed rotavirus infection, the weak co-infecting strain could 
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also be typed even though the RNA electropherotyping may only show one 
single strain. However, it is unlikely that such a large proportion of the short 
electropherotypes contain mixed infections particularly with one co-infecting 
strain at such a low concentration as to fail to be detected in all 18 cases. 
Secondly, it is possible that the specimens were contaminated with G1 
specific dsRNA or cDNA at some stage. All the negative sample and reagent 
controls in the experiment remained unreactive. However, due to the high 
prevalence of the G1 rotavirus types during the study, contamination of stool 
specimens during routine processing would be a likely explanation^^^ This 
highlights one of the major drawbacks of PGR, namely its susceptibility to 
contamination due to the high sensitivity of the method. Sequence analysis 
have shown that G type-specific sequences are conserved so it is unlikely that 
the detection of multiple genotype specificity in these specimens is due to the 
presence of G2 strains possessing a VR-B on the VP7 gene with Gl-
specificity. 
A similar method was used by McCrae'^^ using different primers for 
PCR of rotavirus in stool specimens. The specificity of the assay was also 
poor with multiple serotypes frequently being detected in the clinical isolates, 
even though the assay with the standard strains appeared to work 
satisfactorily. 
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4.8 Specificity analysis of RT-PCR primers 
In the present study, the primers used were as initially reported for RT-
PCR typing by Gouveaio6. Primers for the production of the full-length copy 
of the VP7 gene were directed against the 5丨-and 3'- non-coding regions. 
Those for genotyping were directed against the six type-specific variable 
regions A to F identified in the VP7 (Figs. 1 and 5). The sequences 
were derived from HRV strains 69M (G8), Wa (Gl), DSl (G2), ST3 (G4), 
P(G3)，and WI61 (G9)，respectively. The primer against the 3'-non-coding 
region, END9 or RVG9 was used as the common primer during typing (Fig. 
5). Following analysis of the sensitivity and specificity of the RT-PCR 
method, the primers, particularly those for G3, G8，and G9, were not thought 
to be the most suitable. The DNA sequences of the primers were investigated 
for primer dimerisation and secondary structure using the micro-computer 
software 01igo4 (Macintosh, USA). The primer sequences were compared 
manually, with the nucleotide sequences available for the rotavirus VP7 gene 
within both the Genbank and EMBL databases, and those published but not 
available in either database (sequence data and references shown in 
appendices A4.1-A4.9). Reports with only amino acid sequences were not 
included. 
4.8.1 5，non-coding region (nt 1-28) - primer BEG9 
The first 28 nucleotides ofHuAVa was used to define the 5' non-coding 
region and the sequence data were compared against the Hu/Wa sequence. 
This region proved to be highly conserved in all the strains analysed 
(appendix A4.1). The maximum variations were found in the GIO bovine 
strains A44 and KK3, but both strains have greater than 85% homology^^^ 
4.8.2 3, non-coding region (nt 1033/6-1062) - primers END9/RVG9 
This region was also highly conserved in all the strains analysed 
(Appendix A4.2)，except the Equine strains L338 and FI23, G13, and G14 
29，30. It was shown the VP7 sequence terminated at ntl037 and 1029, 
respectively, possibly because of failure to produce full-length cDNA prior to 
cloning and sequencing^^'^^. 
4.8.3 Variable region A (nt 165-198) - primer aAT8 (G8) 
. T h e r e is a 12% variation between the bovine G8 strain (A5) and the two 
human strains sequenced to date丨。^，！28,257 八 high degree of homology was 
found to exist between the G8 and G9 strains within the region on VR-A to 
which the primer anneals (>82%) and greater than 77% for VR-A as a whole. 
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The G3 rotavirus strains have a homology of at least 88% for this region and 
the G3-specific primers have been shown to cross-react with G8 strains 
producing both G3 and GS-specific products. A difference of 33% in the 
nucleotide sequence exists with G2 strains. A continuous stretch of twelve 
nucleotides (182-193) are homologous in G2 strains to the G8 primer in VR-
A, but four of the last five 3’ nucleotides are different, which should prevent 
mis-priming. 
4.8.4 Variable region B (nt 309-351) - primer aBTl (Gl) 
The four Gl strains varied by less than 7% within the 43 nucleotides of 
VR-B. The maximum homology between the Gl and other types was found in 
a G4 porcine strain (73% against the primer and 77% for VR-B as a whole). 
Up to fifteen nucleotides of continuous homology exist with only the last two 
3’ nucleotides not matching. However, the homology between Gl and G4 was 
64% when only human types are compared. A 60-73% homology is also 
found between Gl and G3 strains (no human strain sequences were available) 
with a porcine strain having a twelve nucleotide stretch of complete 
homology. The Gl primer may anneal to either of the G3 or G4 strains but, as 
the 3' primer end nucleotide is heterologous and so cannot anneal, primer 
elongation should not take place. 
4.8.5 Variable region C (nt 408-438) - primer aCT2 (G2) 
Within the region identified by the primer, less than 10% variability 
exists within the four type G2 strains. Sequence homology varies between 
68% to 40% when G2 was compared with G3 and G4 strains, respectively. 
56% homology exists between G2 and G1 strains within VR-C, however only 
the 3' terminal nucleotide of the last nine primer nucleotides is not 
homologous. Under low stringency conditions, this primer may anneal but 
should not be extended. However a mutation at that site to produce the 
homologous nucleotide would result in primer extension and mis-typing 
would occur. 
4.8.6 Variable region D (nt 477-504)- primer aDT4 (G4) 
The published sequence of Hu/ST-3 differs by one nucleotide with the 
G4 primer described, primer nucleotide six is a cytosine residue but is 
thymidine in the full sequence�", it is most likely the sequence used to 
produce the primer is correct as the other G4 types carry the cytosine residue 
in that position. Intra-type homology varies between 70-95%, (85-95% for 
human strain). There is a high degree of inter-type variation (32-53%) with 
the other genotypes, suggesting there is little chance of mis-priming during 
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following RT-PCR amplification. 
4.8.7 Variable region E (nt 672-711) - primer aET3 (G3) 
Nucleotide sequence data were only available for the primer with Hu/P 
the remainder of the region was defined by Si/SAll. Within the region 
defined by the primer there was a high degree of intra-type variation, up to 
19% within the four Si/SAll strain sequences！。’:〗.This intra-type variation 
was greater than the inter-type variation for G8, 10，and 12 (5-
2qo/,)108,128.256,257 Hkely the G3 primer will anneal to the VR-E of these 
strains. Several monoclonal antibodies directed against this region e.g. mAb 
Yo IE2 bind to both G3 and G8 strains!�丨.Other mAbs (McN3, 4，and 7) 
cross-react with G9 s t r a i n s ^ . This means the minor human types (G8 and 12) 
will produce a PGR product characteristic of G3 strains. 
The three common human types 1，2，and 4 exhibit 53-62% homology 
with that of G3 so it is unlikely that the G3-specific primer will be able to 
anneal to the VR-E of these types. 
4.8.8 Variable region F (nt 747-776) - primer aFT9 (G9) 
Complete homology is found within the region ofVR-F selected by the 
G9 primer for the two G9 strains舰.The primer may be unable to distinguish 
between G9 and G3, G4 or G8 strains, as up to 80, 75, and 75% homology 
exists respectively. This cross-reactivity limits the usefulness of the primer in 
the genotyping of G9 rotavirus. 
A summary of the analysis of these primers is listed in Table 19. The 
primer sequences used were also analysed for homology with other sequences 
using the DNA search function in the DNASIS software using the Genbank 
database. Strains of the same genotype specificity were preferentially selected, 
with the exception of the G3-spedfic primer. The G3-specific primer selected 
strains with G3, G8 and GIO (bovine) specificity this again indicated the 
unsuitability of the G3 primer. 
To further confirm there would be no cross-reaction with nucleic acid 
sequences from non-rotaviral origin, human, MA 104 (monkey kidney cell line 
for rotavirus culture) and non-rotaviral infectious agents causing diarrhoea, 
including Salmonella spp” Aeromonas spp., Shigella spp., Clostridium spp., 
and E. coli were tested and found to be unreactive with the above primers. 
A range of annealing temperatures from 42°C to 52�C was tried for both 
the first (full-length) and second (typing) round of PGR amplification. Raising 
the annealing temperature reduces the chance— of extending mismatched 
primers therefore enhances the specificity of the RT-PCR. Analysis of the 
predicted annealing temperatures of the primers also suggested the optimal 
annealing temperature of the primers to produce the full-length transcript 
Summary of the homology differences between primer 
sequence and type-specific variable regions 
G-type VR Serotype - % difference from primer sequence 
1 2 3 4 8 9 12 
G8 A 67 33-52 0-12 52-57 0-9 18 40 
G1 B 0-4 50 31-45 27-40 45-50 40 45 
G2 C 44 <10 32-40 60 44 35-40 48 
G4 D 68 63 52 5-30/15 52 47 68 
G3 E 53-62 53-62 19 53-62 5-20 33 5-20 
G9 F 30-35 40 20-35 25-35 25-40 0 50 
should be 50.9�C for G1 strains (Table 18). It was fo 
amplification that the sensitivity was reduced as 
increased, so this was left unchanged at 42°C. Fo 
annealing temperature was raised to. 50°C (optimal 
:for the first round 
i temperature was 
le genotyping, the 
lealing temperature 
49.8�C，Table 18), although 42�C also appeared to work satisfactorily. 
Only the G3-specific primer was found to form a stable duplex (-13.3 
Kcal/mol) with itself. Denaturation of the cDNA will also denature the duplex 
so it should not affect the availability of the primer during genotyping. 
Reducing the concentration of enzyme and primers reduces mis-priming, 
especially primer dimerisation. 
4.9 Future developments of the study 
The results from this study, and other reports^ '^'^ '^^ ^^ have shown it is 
still not possible to predict the evolution of predominant HRV strains from year 
to year. The limited understanding of the changes which take place in HRV 
within the community means it will be difficult to formulate an effective 
vaccine，and this has limited the success with vaccine development to 
datei2，i03’"6，i94a，267 jg nccessary to continue the surveillance of HRV in the 
community, with sensitive and specific typing methods such as RT-PCR. 
Firstly, the type-specific primers require re-designing to prevent cross- • 
reaction between genotypes (e.g. between G3 and G8 strains). From analysis of 
the sequence data it has been possible to propose a set of primers which may 
overcome this problem (Tables 20 and 21). There is insufficient difference in 
the nucleotide sequences of several of the type-specific variable regions to 
design sufficient primers to type G1 to G4, G8 and G9 in a single RT-PCR 
reaction (Appendices A4.1-A4.9). It was proposed to have two genotyping 
reactions, the first to type the major human genotypes Gl, G2, G3, and G4. 
The second reaction would be to genotype G8, G9, and G12 strains, if the first 
reaction produced full-length cDNA but could not be genotyped. 
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Nucleotide sequences of proposed primers 
First round genotyping: 
B1 (25) AAG TAG TCA AAT CAA TGA TGG TGA C 
F2( 19) CAT AAA TAT TTC AAT AAA T 
D3(17) ATG ACG CGA CGT TGC AA 
A4(23) TTG TAT TAT CAG TAG TAT CTA AT 
Second round genotyping: 
B8(25) AGA GAC AGA GAT AGC AGA TAG TTC G 
D9( 19) GTA CGA TTC AAC ATT AGA G 
F12(19) GAT CAA TAT TAG ATT GAA T 
Secondly, in this study only the major outer capsid protein VP7 was 
studied, however, the outer capsid protein VP4 has been reported to be capable 
of illiciting more anti-rotavirus neutralising antibody than the V P 7 _ jg 
therefore necessary to monitor the distribution and changes of the VP4 epitopes 
to gain a greater insight into how the virus responds to the host's immune 
response. From this a better understanding of the role of VP4 immunity may be 
gained and hence, also the approach required to develop an effective vaccine 
augmented. 
Relatively few strains have had their VP7 gene sequenced and generally 
only a single sequence has been obtained for these. This 'snap-shot' of the VP7 
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G3， 
• Degree of homology of proposed primers for genotyping Gl，G2， 
G4 HRV strains with sequence data of strains with known 
Genotype (G) Primers - (VR,G-type(size,bp)) 
A4(23) Bl(25) D3(17) F2(19) 
Gl 47-52 <4 41-52 42-47 
G2 47-52 48 41-47 0 
G3 34-43 36-48 <23 47-57 
G4 <21 28-44 76-82. 36-63 
G8 -52 48-56 41-47 42-52 
G9 � 5 6 44 41-47 47 
Table 21 - Degree of homology of proposed primers for genotyping G8, G 
and G12 HRV strains with sequence data of strains with known serotype 
Genotype (G) Primers - (VR, G-type (size, bp)) 
B8(25) D9(19) F12(19) 
Gl 56 52 53 
G2 48 47 26 
G3 36 47 58 
G4 60 47 47 
G8 0 47 32 
G9 52 0 58 
G12 0 
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；s little information about the changes which take place in the 
;it strives to maintain its viability within the environment. Following 
the VP7 gene sequence of several major strain electropherotypes from their first 
identification and at several points over an individual or several consecutive 
seasons, may help us to comprehend how HRV adapts to its environment. This 
study would help us to appreciate the changes which take place within the VP7 
gene at a molecular level. These data will then help us to understand the more 
generalised epidemiology data which is currently used to define the dynamics of 
HRV in the community. 
Appendix 1 
Al . l Tissue culture reagents 
Al.1.1 HEPES buffer IM stock solution (pH 7.3) 
238.3 g of HEPES (Flow Laboratories,UK) was dissolved in 900 ml 
distilled water and the pH adjusted to 7.3 with 5 M NaOH and made up to a 
final volume of 1000 ml. Filter sterilised and stored at 4°C. 
Al.1.2 Sodium bicarbonate stock solution (7.5%) 
7.5 g of sodium bicarbonate (Sigma,USA) was dissolved in 100 ml 
distilled water. The solution was sterilised by autoclaving at 15 lb for 15 
minutes and stored in tightly sealed bottles at 4°C. 
Al.1.3 Gentamicin stock solution (4mg/ml) 
1 ml of gentamicin (40 mg/ml, Roussel Labs,UK) was diluted to a final 
volume of 10 ml with distilled water and stored at 4°C. 
Al.1.4 Trypsin stock solution (2.5%) 
250 mg of crystallised trypsin (Sigma,USA) was added to 10 ml distilled 
water and the preparation was filter sterilised, aliquoted and stored at -20°C. 
Al.1.5 Phosphate buffered saline (PBS, 
50 ml of lOx PBS (Irvine Scientific,USA) was added to 450 ml distilled 
water. The PBS was then sterilised at 15 lb for 15 minutes and stored at room 
temperature. 
Al.1.6 Glutamine stock solution (200mM) 
14.6 g of glutamine (Sigma,USA) was dissolved in 500 ml distilled 
water then aliquoted, filter sterilised and stored at -20"C. 
Al.1.7 EDTA-Trypsin 
EDTA (0.05%): 2.5 ml of* 2% EDTA (Sigma,USA) stock solution was 
made up to 100 ml with PBS, pH 7.2. 
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Trypsin (0.25%): 10 ml 2.5% trypsin was diluted with 90 ml PBS. 
For EDTA-Trypsin, 100 ml of 0.05% EDTA was diluted with 100 ml 0.25% 
Trypsin then filter sterilised, aliquoted and stored at 4°C. 
Al.1.8 Cell culture growth medium - Minimum Essential Medium 
(MEM) • 
MEM-Eagle 
(Earle's salt base lOx) 
(Biological Industries,Israel) 
Glutamine 200 mM 
HEPES 1 M 
Sodium bicarbonate (7.5%) 














For rapid growth of the cell line 50 ml foetal calf serum， 
ofMEM(10%FCS) 
；added to 450 ml 
For the growth of rotavirus, FCS was excluded and trypsin added to the MEM 
to a final concentration 0.5 |ig/ml. 
1.1.9 RMPI - Culture medium for hybridoma cell lines 
lOx RMPI (Gibco,USA) 
distilled water 
Glutamine 200 mM 
HEPESIM 
NaHCOs (7.5%) 
















For 15% FCS RMPI, 64 ml FCS was added to the above medium 
A1.2 Reagents for Electropherotyping 
Al.2.1 0.1 M Sodium Acetate pH 5.0, containing 1% SDS 
Preparation of 0.1 M acetic acid: 6g glacial acetic acid was added to 1.0 
1 distilled water. 1.15 g anhydrous sodium acetate was dissolved in 140 ml 
distilled water (O.IM). 140 ml O.IM sodium acetate was mixed with 60 ml 0.1 
M acetic acid and 2 g Sodium dodecyl sulphate (SDS) added. The pH was 





redistilled phenol (BDH,UK) 
m-cresol (Sigma,USA) 










3 volumes of "phenol" was mixed with 2 volumes of "chloroform".‘ 
mixture was aliquoted and stored at -20°C. 
Al.2.3 30% acrylamide, 0.8% N,N'-methylene-bis-acrylamide (MBA) 
30 g Acrylamide (Sigma, USA) 
MBA (Sigma,USA) 
Dissolved and then made up to 100 ml with distilled > 
Al.2.4 Lower Tris buffer (4x)-1.5M Tris-HCI, pH 
• and stored at 4°C. 
18.17 g of Tris base (BDH,UK) was dissolved in approximately 80 ml of 
distilled water and the pH adjusted to 8.8 with 12 N HCl (Merck,Germ.) 
(approx. 2.75 ml). The volume was made up to 100 ml with distilled water 
and the solution stored at 4°C. 
Al.2.5 Upper Tris buffer (4x)-0.5M Tris-HCI, pH6.8 
6.06 g of Tris base was dissolved in 80 ml of distilled 
137 
• and the pH 
adjusted to 6.8 with 12N HCl (approx. 3 ml). The solution 
100 ml with distilled water and stored at 4°C. 




Al.2.7 Sample buffer 
Upper Tris buffer (4x) 
Glycerol (M+B，USA) 
Bromophenol blue (Sigma,USA) 
Al.2.8 Ammonium persulphate solution (2%) 
Ammonium persulphate (BDH，USA) 
Distilled water 
Al.2.9 Acrylamide Separation gel (10%) 
(2 gels-16 cm X 18 cm X 1.5 mm) 
Distilled water 
Lower Tris (4x) 
30% acrylamide, 0.8% MBA 
N,N,N',N'-Tetramethylethylenediamine 
(TEMED, Biorad, Ca.) 
Ammonium persulphate (2%) 
Al.2.10 Acrylamide Stacking gel (3%) 
Distilled water 
Upper Tris (4x) 
30% acrylamide, 0.8% MBA 
N,N,N',N'-Tetramethylethylenediamine 



















Al.2.11 Fixing SoIution-10% ethanol, 0.5% acetic acid 
Ethanol, absolute 
Glacial Acetic acid 
Distilled water 




Silver Nitrate (BDH，UK) 
Distilled water 
Al.2.13 Developing (reducing) Solution 
Sodium hydroxide (M+B,USA) 
Formaldehyde solution (38%)(M+B,USA) 
Distilled water 
Note: Do not add formaldehyde directly to solid NaOH 
Al.2.14 Stopping Solution - Acetic acid (5%) 
Glacial acetic acid (Merck,Germ.) 
Distilled water 
Al.2.15 Tris-borate electrophoresis (TBE) buffer 
Tris-base 
Boric acid (M+B，USA) 
0.5 M EDTA，pH 8.0 
Distilled water 










1 g of ethidium bromide (Sigma,USA) was dissolved in 100 ml distilled 
water and required several hours of constant stirring. The preparation was 
aliquoted and stored at 4°C in a covered container. 
A1.3 Reagents used during primer synthesis 
Al.3.1 Ammonium Hydroxide (3%) 
Ammonium hydroxide (30%) (M+B,UK) 10 ml 
Distilled water . 90 ml 
Al.3.2 Triethylammonium acetate (TEAA 1 M, pH 7.0) 
30 ml of glacial acetic acid was added to 800 ml distilled water. 139.4 
ml of triethylamine was then added. The pH was adjusted to 7.0 with glacial 
acetic acid and the volume adjusted to 1000 ml with distilled water. 
Al.3.3 Trifluoroacetic acid (TFA, 2%) 
Trifluoroacetic acid (Merck,Germ.) 2 ml 
Distilled water 98 ml 
Al.3.4 Acrylamide gel solution (15%, cross-linking 4%) 
Acrylamide 14 4 g 
MBA 0.6 g 
Urea (BDH，UK) 42 04 g 
buffer was added and 
was filtered. 
J dissolved in 50 ml distilled 
100 ml with distilled 
10 ml lOx TBE 
ter. The solution 
For 2 gels the following were { 
Gel solution 
ammonium persulphate (0.1 g 
TEMED 
Al.3.5 Loading Buffer (2x) 










A1.4 Reagents for the Enzyme Immunoassays 
Al.4.1 Sodium Bicarbonate (NajHCOa) buffer, pH9.8 
Na2HC03 
Na2C03 





Tween 20 0.5 ml 
1000 ml 
Al.4.3 Alkaline Phosphatase substrate (pNpp) 
i Substrate buffer 






The pH was adjusted to 9.8 with HCl and then made up to 500 ml with dHzO 
and stored at 4°C. 
When the pNpp was required the substrate buffer was used to dilute the p-
Nitrophenyl phosphate to 1 mg/ml. 
The substrate was tested by mixing 5 [x\ 1/1000 dilution alkaline phosphatase 
conjugate with 100 }il substrate and the OD measured at 405 nm to confirm 
the colour change is sufficient. 
Al.4.4 Horse Radish Peroxidase substrate 
One a-phenylenediamine. 2HCI (OPD) tablet (12.8 mg, Abbott Labs, USA) 
was dissolved in 5 ml OPD diluent (citrate-phosphate buffer containing 0.02% 
hydrogen peroxide, Abbott Labs, USA). 5 ml was enough for 13 tests. 
A1.5 Reagents used in the Polymerase Chain Reaction 
Al.5.1 Cetyl(hexadecyl)trimethylammonium bromide (CTAB,10%) 
CTAB (Merck,Germany) 
ddHzO 
Aliquoted and stored at 20°C. Redissolved at 57°C prior to use. 
Al.5.2 Sodium chloride (NaCI,4 M) 
NaCl 
ddH^O 
Aliquoted and sterilised by autoclaving. 
Al.5.3 2'-deoxythymidine 5'-triphosphate (dTTP,10 mM) 
dTTP (Pharmacia,Swe.) 
ddH20 
Filter sterilised, aliquoted, and stored at -20°C. 
AI.5.4 2'-deoxyguanosine 5'-triphosphate (dGTP，10 mM) 
dGTP (Pharmacia,Swe.) 
ddHiO 
Filter sterilised, aliquoted and stored at -20°C. 
Al.5.5 2,-deoxyadenosine 5'-triphosphate (dATP,10 mM) 
dATP (Pharmacia,Swe.) 
ddH20 
Filter sterilised, aliquoted and stored at -20�C. 
Al.5.6 2'-deoxycytidine 5’-triphosphate (dCTP，10mM) 
dCTP (Pharmacia,Swe.) 
dclHzO 
Filter sterilised, aliquoted and stored at -20�C. 
50.0 ml 
2 3 . 4 g 




5 6 9 . 1 g 
10.0 ml 
Al.5.7 RT reagents 
Stock conc vol/|il 
RT buffer (Promega,UK) 
Reverse transcriptase (Promega,UK) 
RNasin (Promega,USA) 
BSA，nuclease free (Pharm,Sweden) 
Primers BEG9 
END9 






















A brief pulse from a micro-centriftige i 
bottom of the microcentrifuge tube. 
Al.5.8 PGR full-length cDNA master mix 
used to deposit the sample at the 
PGR buffer (Amersham,UK) 1 Ox 









Al.5.9 PCR genotyping master mix 
PGR buffer (Amersham，UK) 
Taq Polymerase (Amersham,UK) 






A1.6 General reagents 
Al.6.1 3M sodium acetate (pH 5.2) 
40.8 g of hydrated (3H2O) sodium ； 


















:(BDH,UK) was dissolved in 
80 ml of distilled water and the pH adjusted to 5.2 with glacial acetic acid. 
The volume was made up to 100 ml with distilled water. 
Al.6.2 0.5mM Ethylene diamine tetraacetic acid (EDTA, pH8.0) 
18.6 g of (disodium salt) EDTA was added to 80 ml d H : � a n d issolved 
by stirring vigorously with a magnetic stirrer. As pH was adjusted to 8.0 with 
10 M NaOH the EDTA dissolved. The preparation was aliquoted and 
sterilised by autoclaving. 
Al.6.3 Preparation of dialysis tubing 
15 cm strips of dialysis tubing (Medicell Int,UK) were cut and 
autoclaved for 10 minutes on liquid cycle in a loosely capped jar containing 
distilled water. 
Al.6.4 Tris-EDTA buffer (TE, pH 8.0) 
10 mM Tris-HCl 
1 mM EDTA (disodium salt), pH8.0 
Appendix 2 
Figures refer to: number of cases-repeated specimens e.g. in A2.2 *4-2, refers 





-Distribution of electropherotypes between July 1985 and June 1986 
Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jim 
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A2.3 _ Distribution of electropherotypes between July 1987 and June 1988 
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-Distribution of electropherotypes between July 1988 and June 1989 
:Jul Aug Sep Oct Nov Dec Jan Feb M Apr May Jun 
L022 
L023 
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• Distribution of electropherotypes between July 1989 and June 1990 

































A2.8 - Distribution of long electropherotypes between July 1992 and June 1993 






































• Distribution of electropherotypes between July 1989 and June 1990 
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A3.1 - Electropherotypes of HRV strains: Wa, 






A3.2 - Electropherotypes of HRV strains: LOlO, L027, 
L005, L030, L013, L017, L021, L028, L036，L032，L044 
L107’ LI 11，LI26, LI29, L038, SAl l , S2 
2.3 
-Electropherotypes of HRV strains: L104, L087, L096, L092, L083 
’ LlOl, L081, LlOO，L091, L106, LI 10, L122, L112, L019, L022, L020 
，L073, L055, L052, L053 ’ 
Imh. 
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A3.4 - Electropherotypes of HRV strains: LI 15, L066, L026, L029 
L031，L034, L043, L042，L123, L121, LI 18’ L117, LI 16，LI 19, L102 
L046，L039, L063, L090，L049, L061, L059, L050 ’ 
Electropherotypes of HRV strains: L109, L085, L124, L185, L145 
L094，L125, L127, L128，L133，L130, LI 13，L141, L136, L137, L138， 
— — 精 麵 
• _ mm f i 
A3.6 - Electropherotypes of HRV strains: Wa, L154, L155, L164 L166 
L075，L146, L108，L143, L103, L142, L145, L077, L179, L159, L171 L167， 






 m mM _ _ 
2.3 
A3.7- Electropherotypes of HRV strains: L156, L158, L160, L161, L162, 
L163，L149, L140, L147, L165, L157, L174, L170, L148, L152, L151, L187, 
L172 
M 
A3.8 - Electropherotypes of HRV strains: Wa，SOOO, 
S004, so i l , S006, S007, S008, S015, S009, SOlO，S017, 
S2, SAl l 
S012, S021, 
2.3 
A3.9 - Electropherotypes of HRV strains: Long, S020, S013, S024, S023, 
S022, S014, S019, S016, S015, S002, S2, Wa 
A3.10 - Electropherotypes of HRV strains: RV5, Long, 
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Unless sequence variation was observed within the following strains 
only a single sequence was shown. Individual strains containing the variation 
were marked with an asterix. For Hu/Wa (Gl) only R029 (not R0HVP7A); 
for Si/SAll (G3) ROTROTl (not R01VP7，R01G9’ ROTSIll); for 
Po/Gottfried (G5) PRV0PR9 (not PRVPRVP7); and Bo/UK (G6) ROBG (not 
ROBROTAUK) 
A4.9 - RV strains and nucleotide sequence references for the VP7 gene 
Rotavirus strains (geno/serotype) References 
A/Si/SA11(G3) 23，10 








A/Po/OSU (G5) 96: 225 
A/Si/RRV(G3) 60 
A/Hu/D(G1), MO(Gl), M37(G1), P(G3), DS1(G2), 
HN 126(02), VA70(G4)，ST-3(G4) 109 
A/Po/Gottfried(G4) , 102 
A/Po/YM(GU) 223 
A/Hu/KU(G1) 254 
A/Hu/69M(G8), WI61(G9), F45(G9) 108 




255 A/DO/O I 
A/Hu/L26(G12), L27(G12) 256 
A/Hu/St Thomas-3(G4) (9) 217 
A/Bo/B223(G10) (8) 282 
A/Hu/RV-5(G2) 64 
A/Bo/C486(G6) 228 
A/Po/CRW-8(G3), AT/76(G3), BEN-1(G4), TFR- 127 
4 1 ( 0 5 ) 
A/Eq/L338(G13) 29 
A/Bo/KK3(G10),A44 (G10)，A5(G8) 257 
A/Po/K(G4) 3 
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